<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:svg="http://www.w3.org/2000/svg" lang="en" xml:lang="en">
<head>
<title>12.2 G Protein–Coupled Receptors and Second Messengers in Chapter 12 Biochemical Signaling</title>
<meta charset="utf-8"/>
<meta content="final" name="process"/>
<meta content="part" name="book_type"/>
<meta content="3.3" name="schema"/>
<link href="../styles/nel_9781319228002.css" rel="stylesheet" type="text/css"/>
<meta content="urn:uuid:e0000000-0000-0000-0000-000006631217" name="Adept.expected.resource"/>
</head>
<body class="bodymatter" epub:type="bodymatter">
<section class="sect1" id="dav_9781319322342_xSy6h6JZ3n">
<header id="dav_9781319322342_POeGu8qq9P"><h3 class="a-head v1" id="dav_9781319322342_2pfukEoJXX">12.2 G Protein–Coupled Receptors and Second Messengers</h3></header>
<p class="noindent" id="dav_9781319322342_jwV2xGz6Uk">As their name implies, <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_M63UhZARH5"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_XtJX1j1OMI" id="dav_9781319322342_tYwIAHdDlc" role="doc-glossref">G protein–coupled receptors (GPCRs)</a></dfn> are receptors that act through a member of the <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_hzCFDSsLIn"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_k6wXYe3q8u" id="dav_9781319322342_8T5pDwVUNV" role="doc-glossref">guanosine nucleotide–binding protein</a></dfn>, or <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_D7Cr3VAM1p"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_z0YwK0dyEY" id="dav_9781319322342_3wliCM4XRY" role="doc-glossref">G protein</a></dfn>, family. <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_6pIUx9sHFE" role="presentation" src="../images/nelsonlehnpob8e_PG01c.png"/> Three essential components define signal transduction through GPCRs: a plasma membrane receptor with seven transmembrane helical segments, a G protein that cycles between active (guanosine triphosphate (GTP)-bound) and inactive (guanosine diphosphate (GDP)-bound) forms, and an effector enzyme (or ion channel) in the plasma membrane that is regulated by the activated G protein. An extracellular signal such as a hormone, growth factor, or neurotransmitter is the “first messenger” that activates a receptor from outside the cell. Ligand binding to the receptor forces an allosteric transition that allows the receptor to interact with a G protein, causing it to exchange its bound GDP for a GTP from the cytosol. The G protein then dissociates from the activated receptor and binds to the nearby effector enzyme, altering its activity. The effector enzyme then causes a change in the cytosolic concentration of a low molecular weight metabolite (such as <span class="math" id="dav_9781319322342_lTq08JxLci" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="3 prime" src="../images/MATH/nel_9781319228002_ch12_03EQ_0001.png"/></annotation-xml></semantics></math></span>,<span class="math" id="dav_9781319322342_SfjTUc8nmq" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mn>5</mn><mo>′</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="5 prime" src="../images/MATH/nel_9781319228002_ch12_03EQ_0002.png"/></annotation-xml></semantics></math></span>-cyclic AMP) or inorganic ion <span class="math" id="dav_9781319322342_1yDpoOZitt" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msup><mtext>Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis Ca Superscript 2 plus Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0003.png"/></annotation-xml></semantics></math></span>, which acts as a <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_2tHXDJFUKs"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_UmQ5cRJrVc" id="dav_9781319322342_PTl9FqFozV" role="doc-glossref">second messenger</a></dfn> to activate or inhibit one or more downstream targets, often protein kinases.</p>
<p class="indent" id="dav_9781319322342_BFUOcnQBbT"><img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_kPRiPZ8WPK" role="presentation" src="../images/nelsonlehnpob8e_IC_pg_37.png"/> The human genome encodes just over 800 GPCRs, about 350 for detecting hormones, growth factors, and other endogenous ligands, and up to 500 that serve as olfactory (smell) and gustatory (taste) receptors. The largest superfamily of proteins encoded in the human genome, GPCRs have been implicated in many common medical conditions, including allergies, depression, blindness, diabetes, and various cardiovascular defects. GPCR mutations are also found in 20% of all cancers. In the United States, more than a third of <i class="semantic-i" id="dav_9781319322342_6NdtbIM3jy">all</i> pharmaceuticals on the market target a GPCR. For example, the <i class="semantic-i" id="dav_9781319322342_Jai8sX8skQ">β</i>-adrenergic receptor, which mediates the effects of epinephrine, is the target of the “beta blockers,” prescribed for such diverse conditions as hypertension, cardiac arrhythmia, glaucoma, anxiety, and migraine headache. More than 100 of the GPCRs found in the human genome are still “orphan receptors,” meaning that their natural ligands are not yet identified, and so we know little about their biology. The <i class="semantic-i" id="dav_9781319322342_tDiqIABCTg">β</i>-adrenergic receptor, with well-understood biology and pharmacology, is the prototype for all GPCRs, and our discussion of signal-transducing systems begins there. <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_Si9pon20d3" role="presentation" src="../images/nelsonlehnpob8e_01_pg36.png"/></p>
<section class="sect2" id="dav_9781319322342_amSdKJ6iqr">
<header id="dav_9781319322342_qfbzQ25mlb"><h4 class="b-head v3" id="dav_9781319322342_GKJCf0BskE">The <i class="semantic-i" id="dav_9781319322342_vIPQfHlEgz">β</i>-Adrenergic Receptor System Acts through the Second Messenger cAMP</h4></header>
<p class="noindent" id="dav_9781319322342_3SM2qcG98V">Epinephrine released from the adrenal glands sounds the alarm when a threat requires an animal to mobilize its energy-generating machinery; it signals the need to fight or flee. Epinephrine action begins when the hormone binds to a protein receptor in the plasma membrane of an epinephrine-sensitive cell (a myocyte in muscle, for example). <strong class="important" id="dav_9781319322342_SffBX0cPxj">Adrenergic receptors</strong> (“adrenergic” reflects the alternative name for epinephrine, adrenaline) are of four general types, <span class="math" id="dav_9781319322342_HdymwhZUUJ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>α</mi><mn>1</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="alpha 1" src="../images/MATH/nel_9781319228002_ch12_03EQ_0004.png"/></annotation-xml></semantics></math></span>, <span class="math" id="dav_9781319322342_g0GmInyhMD" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>α</mi><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="alpha 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0005.png"/></annotation-xml></semantics></math></span>, <span class="math" id="dav_9781319322342_U1TYlQ3NtO" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>β</mi><mn>1</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="beta 1" src="../images/MATH/nel_9781319228002_ch12_03EQ_0006.png"/></annotation-xml></semantics></math></span>, and <span class="math" id="dav_9781319322342_46GwrpU06I" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>β</mi><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="beta 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0007.png"/></annotation-xml></semantics></math></span>, defined by differences in their affinities and responses to a group of agonists and antagonists. <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_MlPZes8tt9"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_qUqiR9YRcX" id="dav_9781319322342_2uCuZgUaAf" role="doc-glossref">Agonists</a></dfn> are molecules (natural ligands or their structural analogs) that bind a receptor and produce the effects of the natural ligand; <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_OM1FeKTJuS"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_eGTXNSkVzy" id="dav_9781319322342_37LEq8Lujt" role="doc-glossref">antagonists</a></dfn> are analogs that bind the receptor without triggering the normal effect and thereby block the effects of agonists, including the natural ligand. In some cases, the affinity of a synthetic agonist or antagonist for the receptor is greater than that of the natural agonist <span aria-label="413" epub:type="pagebreak" id="page413" role="doc-pagebreak"/>(<strong class="important" id="dav_9781319322342_h9UUm94M7L"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_mYnNd3Pbme" id="dav_9781319322342_5jZqtAUKk4">Fig. 12-3</a></strong>). The four types of adrenergic receptors are found in different target tissues and mediate different responses to epinephrine. Here we focus on the <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_8YyaFujyDr"><i class="semantic-i" id="dav_9781319322342_4ZqGxfrGTE">β</i>-adrenergic receptors</dfn> of muscle, liver, and adipose tissue. These receptors mediate changes in fuel metabolism, as described in <a class="crossref" href="nel_9781319228002_ch23_01.xhtml#dav_9781319322342_CGFXSBSGw7" id="dav_9781319322342_fHcjnkIUKq">Chapter 23</a>, including the increased breakdown of glycogen and fat. Adrenergic receptors of the <span class="math" id="dav_9781319322342_NAJPUTbjPr" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>β</mi><mn>1</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="beta 1" src="../images/MATH/nel_9781319228002_ch12_03EQ_0008.png"/></annotation-xml></semantics></math></span> and <span class="math" id="dav_9781319322342_q5IggFsTsO" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>β</mi><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="beta 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0009.png"/></annotation-xml></semantics></math></span> subtypes act through the same mechanism, so in our discussion, “<i class="semantic-i" id="dav_9781319322342_IOrgo1lPnV">β</i>-adrenergic” applies to both types.</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_mYnNd3Pbme">
<img alt="A figure shows the structure and dissociation constants of epinephrine and two synthetic analogs: isoproterenol and propranolol." aria-describedby="dav_9781319322342_2Dtqr9RMlh" class="figure" id="dav_9781319322342_DIr1OKywDh" src="../images/nelsonlehnpob8e_12_03_301706.png"/>
<figcaption id="dav_9781319322342_ro1whzJ30s">
<p class="noindent" id="dav_9781319322342_7WvtF1hvCM"><span class="label" epub:type="label" id="dav_9781319322342_pR7OKAW02e">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_3pLG4xxr5e">12-3 </span><span class="title" id="dav_9781319322342_UmKtGhMxWm">Epinephrine and its synthetic analogs.</span> Epinephrine regulates energy-yielding metabolism in muscle, liver, and adipose tissue. Its affinity for its receptor is expressed as a dissociation constant for the receptor-ligand complex. Isoproterenol and propranolol are synthetic analogs, one an agonist with an affinity for the receptor that is higher than that of epinephrine, and the other an antagonist with extremely high affinity.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_2Dtqr9RMlh" title="hidden">
<p class="noindent" id="dav_9781319322342_ciBmZiKpZH">Epinephrine has a benzene ring with the left side vertex bonded to O H, the lower left vertex bonded to O H, and the right side vertex bonded to C H bonded to O H above and to C H 2 bonded to N H bonded to C H 3. K subscript d end subscript (mu M) equals 5. Isoproterenol (agonist) has a similar structure, except that the terminal C of the chain bonded to the right side vertex of benzene is bonded to H and 2 C H 3 instead of 3 H. K subscript d end subscript (mu M) equals 0.4. Propranolol has a benzene ring that shares its right side with a second benzene ring that has its top vertex bonded to O bonded to C H 2 bonded to C H bonded to O H above and to C H 2 to the right further bonded to N H bonded to C H bonded to C H 3 above and below. K subscript d end subscript (mu M) equals 0.0046.</p>
</aside>
<p class="indent" id="dav_9781319322342_4qZYsDHdI2"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_nZEfM0vVOu" role="presentation" src="../images/nelsonlehnpob8e_PG01c.png"/> Like all GPCRs, the <i class="semantic-i" id="dav_9781319322342_gkGnCblY4Y">β</i>-adrenergic receptor is an integral protein with seven hydrophobic, helical regions of 20 to 28 amino acid residues that span the plasma membrane seven times, thus the alternative names for GPCRs: <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_7X7OScd5yo">seven-transmembrane (7tm) or heptahelical receptors</dfn>. GPCRs effect signal transduction through interaction with <strong class="important" id="dav_9781319322342_2dESuMeVay">heterotrimeric G proteins</strong>, a conserved family of signaling proteins with three subunits, <i class="semantic-i" id="dav_9781319322342_moa50kjbVQ">α</i>, <i class="semantic-i" id="dav_9781319322342_SiJkv0rpX9">β</i>, and <i class="semantic-i" id="dav_9781319322342_mZW01Cfotp">γ.</i> The binding site for GDP or GTP is on the <i class="semantic-i" id="dav_9781319322342_wZn5bimCn7">α</i> subunit. When GDP is bound, the G protein is in its trimeric, inactive form.</p>
<p class="indent" id="dav_9781319322342_sBKi5j3UX4">GPCRs are allosteric proteins. When epinephrine binds to the <i class="semantic-i" id="dav_9781319322342_VpyAMX1KDX">β</i>-adrenergic receptor (<strong class="important" id="dav_9781319322342_Evi6TtveIM"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_J0iHLT2Ncj" id="dav_9781319322342_doBphlPeui">Fig. 12-4a</a></strong>, step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_9U1Z4H0nSN" role="presentation" src="../images/1a.png"/>), allosteric transitions in the receptor and its associated G protein favor the replacement of GDP with GTP. Thus the hormone-bound GPCR acts as a <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_RczZ2xTeYc"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_cNJ7GXoPbM" id="dav_9781319322342_ooLKq6nIT0" role="doc-glossref">guanosine nucleotide–exchange factor (GEF)</a></dfn>. In this active form, the G protein (step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_InPUok4SBL" role="presentation" src="../images/2.png"/>) can transmit the signal from the activated receptor to the downstream effector protein, adenylyl cyclase. Because this G protein stimulates its effector, it is referred to as a <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_2HVvvBpbWj"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_OtuPSs20Xw" id="dav_9781319322342_1bPStkJQ9x" role="doc-glossref">stimulatory G protein</a></dfn>, or <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_TR3rF3Webi"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_OtuPSs20Xw" id="dav_9781319322342_2AcMKg2QPo" role="doc-glossref"><span class="math" id="dav_9781319322342_hMm9z77x0D"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext mathvariant="bold">G</mtext><mtext mathvariant="bold">s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold upper G Subscript bold s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0010.png"/></annotation-xml></semantics></math></span></a></dfn>. In the active form, the <i class="semantic-i" id="dav_9781319322342_aNjDsKe3p1">β</i> and <i class="semantic-i" id="dav_9781319322342_fKAeQ0yDHN">γ</i> subunits of <span class="math" id="dav_9781319322342_StBlQH5us8" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0011.png"/></annotation-xml></semantics></math></span> dissociate from the <i class="semantic-i" id="dav_9781319322342_wZN7HOR8UA">α</i> subunit as a <i class="semantic-i" id="dav_9781319322342_Cy0nJ6MHS8">βγ</i> dimer, and <span class="math" id="dav_9781319322342_84pNlhMxnk" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0012.png"/></annotation-xml></semantics></math></span>, with its bound GTP, moves in the plane of the membrane from the receptor to a nearby molecule of adenylyl cyclase (step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_ejbR4Pw26B" role="presentation" src="../images/3.png"/>).</p>
<figure class="figure lm_img_lightbox num c4 center" id="dav_9781319322342_J0iHLT2Ncj">
<img alt="A two-part figure shows the steps involved in transduction of the epinephrine signal as an illustration of steps within the cell in part a and by showing the conversion of A T P to A M P in part b." aria-describedby="dav_9781319322342_qJ9ev5LUDX" class="figure" id="dav_9781319322342_uYbUz2aAm0" src="../images/nelsonlehnpob8e_12_04ab_301707.png"/>
<figcaption id="dav_9781319322342_CTl9WSXISt">
<p class="noindent" id="dav_9781319322342_akbQZIlhC2"><span class="label" epub:type="label" id="dav_9781319322342_PyVDqQIQRB">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_fwgGzpfIls">12-4 </span><span class="title" id="dav_9781319322342_vUuiJKmUvr">Transduction of the epinephrine signal: the <i class="semantic-i" id="dav_9781319322342_hsyTLDyhjF">β</i>-adrenergic pathway. </span>(a) The mechanism that couples binding of epinephrine to its receptor with activation of adenylyl cyclase; the seven steps are discussed in the text. The same adenylyl cyclase molecule in the plasma membrane may be regulated by a stimulatory G protein <span class="math" id="dav_9781319322342_JGqROeD5R9" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msub><mtext>G</mtext><mtext>s</mtext></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis upper G Subscript s Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0013.png"/></annotation-xml></semantics></math></span>, as shown, or by an inhibitory G protein (<span class="math" id="dav_9781319322342_3dwJ6uDcuf" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>i</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript i" src="../images/MATH/nel_9781319228002_ch12_03EQ_0014.png"/></annotation-xml></semantics></math></span>, not shown). <span class="math" id="dav_9781319322342_3oV0UmxWuv" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0015.png"/></annotation-xml></semantics></math></span> and <span class="math" id="dav_9781319322342_qxYfio3d45" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>i</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript i" src="../images/MATH/nel_9781319228002_ch12_03EQ_0016.png"/></annotation-xml></semantics></math></span> are under the influence of different hormones. Hormones that induce GTP binding to <span class="math" id="dav_9781319322342_GQCVYEwomQ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>i</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript i" src="../images/MATH/nel_9781319228002_ch12_03EQ_0017.png"/></annotation-xml></semantics></math></span> cause <i class="semantic-i" id="dav_9781319322342_zVmEbVl0w1">inhibition</i> of adenylyl cyclase, resulting in lower cellular [cAMP]. (b) The combined action of the enzymes that catalyze steps <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_ghaVi5OQ0i" role="presentation" src="../images/4.png"/> and <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_1ZIZ8NlzCQ" role="presentation" src="../images/7.png"/>, synthesis and hydrolysis of cAMP by adenylyl cyclase and cAMP phosphodiesterase, respectively.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_qJ9ev5LUDX" title="hidden">
<p class="noindent" id="dav_9781319322342_DDhCoZghct">Part a shows a horizontal piece of membrane with the area above labeled outside and the area below labeled inside. A roughly rectangular protein extends across the membrane. A strand begins at an end labeled N above the upper left of the protein and runs vertically down, then up, then down, then slightly to the left as it becomes darker in color, then runs up to the upper right corner, then down to the lower right corner before bending left for a short distance and becoming very pale before running up and looping over a small piece with a hexagon that has a protrusion from one side representing epinephrine that is in front of the previous loop. The pale strand then bends down to the left, bends sharply to the right as it becomes dark and then bends sharply left at the lower center of the rectangular protein, and then leaves the protein at the lower left to end at C within a green oval labeled G subscript s Greek letter alpha. The oval extends to the left from its top side, where a thread extends up halfway through the membrane, and it joins a curved piece labeled G subscript s Greek letter gamma that wraps back toward the piece labeled G subscript s Greek letter alpha. At the right top side of the green piece labeled G subscript s Greek letter gamma, there is a thread that extends up halfway through the membrane. Another oval, which is labeled G subscript s Greek letter beta, is between these two pieces and has a thick tail that extends slightly beneath the right side of G subscript s Greek letter gamma, which curves beneath it. Step 1: Epinephrine binds to its specific receptor. A molecule with a hexagon with a protrusion from its lower left is shown above with an arrow pointing to the similar molecule within the roughly rectangular molecule that extends across the membrane, showing how epinephrine reached that location. There is a gray oval labeled G D P in the middle of the large green oval labeled G subscript s Greek letter alpha. Step 2: Allosteric change in hormone-receptor complex causes the G D P bound to G subscript Greek letter alpha to be replaced by G T P, activating G subscript S Greek letter alpha. An arrow pointing right has curved arrows showing a gray oval labeled G D P leaving and an orange arrow labeled G T P coming in. Step 3: Activated G subscript s Greek letter alpha separates from G subscript s Greek letter beta Greek letter gamma, moves to adenylyl cyclase, and activates it. Many G subscript s Greek letter alpha subunits may be activated by one occupied receptor. The product is a single large green G subscript s Greek letter alpha that has bent so that it is now almost vertical. G subscript s Greek letter beta and G subscript s Greek letter gamma are not present. A protrusion from the upper right of G subscript s Greek letter alpha joins with a large square that extends across the membrane with its top half divided vertically into two halves and labeled adenylyl cyclase. Short arrows radiate out from all sides of adenylyl cyclase and G subscript s Greek letter alpha. Step 4: Adenylyl cyclase catalyzes the formation of c A M P. An arrow begins at A T P, curves through adenylyl cyclase, and then extends vertically down to a purple structure shaped like a rectangle joined with a triangle above with its top vertex pointing upward and labeled c A M P. Two arrows extend from this purple structure. One arrow points right to text reading, 5. c A M P activates P K A, from which an arrow points to text reading, 6. Phosphorylation of cellular proteins by P K A causes the cellular response to epinephrine. The second arrow is labeled cyclic nucleotide phosphodiesterase and points down to 5 prime A M P accompanied by text reading, 7. c A M P is degraded, reversing the activation of P K A. Part b shows the conversion of A T P to adenosine 5 prime monophosphate (A M P). A T P has a five-membered ring with O substituted for C at position 6 at the top vertex, C 1 prime bonded to N of the lower right vertex of a five-membered ring above and to H below, C 2 prime and C 3 prime bonded to H above and O H below, C 4 prime bonded to C 5 prime above and to H below, and C 5 prime bonded to 2 H and to O bonded to P double bonded to O above, bonded to O minus below, and bonded to P to the left double bonded to O above, bonded to O minus below, and bonded to P on the left double bonded to O above, bonded to O minus below, and bonded to O minus to the left. The five-membered ring shares its left side with a six-membered ring. It has N substituted for C at its upper right vertex at position 7, a double bond at its upper right side between positions 7 and 8, a double bond at its left side between positions 4 and 5, and N substituted for C at its lower right vertex at position 9 and further bonded to C 1 prime of the ring below. The six-membered ring has double bond at its right side between positions 4 and 5 shared with the five-membered ring, a double bond at its upper left side between positions 1 and 6, a double bond at its lower left side between positions 2 and 3, N substituted for C at its upper left vertex at position 1, N substituted for C at its bottom vertex at position 3, and its top vertex, C 6, bonded to N H 2. An arrow pointing right is labeled adenylyl cyclase and has an arrow from it showing that P P subscript 1 leaves. This yields adenosine 3 prime, 5 prime-cyclic monophosphate (c A M P). It has a similar structure to A T P except that C 3 prime is bonded to H above and to O below that is bonded to P to the left that is bonded to O minus below, double bonded to O to the left, and bonded to O above that is bonded to C 5 prime on the right that is bonded to 2 H and to C 4 prime of the ring below. An arrow pointing right is labeled cyclic nucleotide phosphodiesterase and is joined by an arrow representing the addition of H 2 O. This yields adenosine 5 prime-monophosphate. It has a similar structure except that C 3 prime is bonded to H above and O H below and C 5 prime is bonded to 2 H and to O bonded to P double bonded to O above and bonded to O minus below and to the left.</p>
</aside>
<p class="noindent" id="dav_9781319322342_pfYEoaMW6Y"><dfn class="keyword" epub:type="keyword" id="dav_9781319322342_alYfb7HwZN">Adenylyl cyclase</dfn> is an integral protein of the plasma membrane, with its active site on the cytoplasmic face. The association of active <span class="math" id="dav_9781319322342_TtMDeYiFaJ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0018.png"/></annotation-xml></semantics></math></span> with adenylyl cyclase stimulates the cyclase to catalyze the synthesis of second messenger cAMP from ATP (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_J0iHLT2Ncj" id="dav_9781319322342_7EXJ0Kk5pV">Fig. 12-4a</a>, step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_SoofmReB1R" role="presentation" src="../images/4.png"/>; <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_J0iHLT2Ncj" id="dav_9781319322342_RkRZ9v2UZ0">Fig. 12-4b</a>), raising the cytosolic [cAMP]. The interaction between <span class="math" id="dav_9781319322342_rGlXr6YOP1" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0019.png"/></annotation-xml></semantics></math></span> and adenylyl cyclase occurs only when <span class="math" id="dav_9781319322342_mcGEu5F7RX" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0020.png"/></annotation-xml></semantics></math></span> is bound to GTP.</p>
<p class="indent" id="dav_9781319322342_jgeTrnnx94">The stimulation by <span class="math" id="dav_9781319322342_h0FZ4LC0nQ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0021.png"/></annotation-xml></semantics></math></span> is self-limiting; <span class="math" id="dav_9781319322342_s0mA5edM4E" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>G</mi><mrow><mi>s</mi><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0022.png"/></annotation-xml></semantics></math></span><i class="semantic-i" id="dav_9781319322342_pvDCgK225E"> has intrinsic GTPase activity that switches <span class="math" id="dav_9781319322342_j0fkjW7g9i" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>G</mi><mrow><mi>s</mi><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0023.png"/></annotation-xml></semantics></math></span> to its inactive form</i> by converting its bound GTP to GDP (<strong class="important" id="dav_9781319322342_2fkA4TuenN"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_bU5WDwvdmY" id="dav_9781319322342_Ja25emWDjT">Fig. 12-5</a></strong>). The inactive <span class="math" id="dav_9781319322342_j9vi72kCQJ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0024.png"/></annotation-xml></semantics></math></span> dissociates from adenylyl cyclase, rendering the cyclase inactive. <span class="math" id="dav_9781319322342_HxdmbKKC7X" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0025.png"/></annotation-xml></semantics></math></span> reassociates with the <i class="semantic-i" id="dav_9781319322342_QneSvIxJFx">βγ</i> dimer <span class="math" id="dav_9781319322342_z3wQysjC3C" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>β</mi><mi>γ</mi></mrow></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis upper G Subscript s beta gamma Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0026.png"/></annotation-xml></semantics></math></span>, and inactive <span class="math" id="dav_9781319322342_8sYeFLxgt4" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0027.png"/></annotation-xml></semantics></math></span> is again available to interact with a hormone-bound receptor.</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_bU5WDwvdmY">
<img alt="A figure shows how the G T P ase switch works, with G proteins cycling between an on position with bound G T P and an off position without bound G T P." aria-describedby="dav_9781319322342_9QDfMMZh2b" class="figure" id="dav_9781319322342_4bxTKdAWnj" src="../images/nelsonlehnpob8e_12_05_301709.png"/>
<figcaption id="dav_9781319322342_1I95oYZAMk">
<p class="noindent" id="dav_9781319322342_LRPbVfyaMC"><span class="label" epub:type="label" id="dav_9781319322342_xGPE8xvE42">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_KatKC2kA7f">12-5 </span><span class="title" id="dav_9781319322342_6u0CMMVVx4">The GTPase switch.</span> G proteins cycle between GDP-bound (off) and GTP-bound (on). The protein’s GTPase activity, in many cases stimulated by RGS proteins (<i class="semantic-i" id="dav_9781319322342_fZJkmUt4xr">r</i>egulators of <i class="semantic-i" id="dav_9781319322342_3U5j9bYF8s">G</i>-protein <i class="semantic-i" id="dav_9781319322342_uxD75CfMsV">s</i>ignaling; see <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_pzaM52Svls" id="dav_9781319322342_b9Hznk0IYi">Fig. 12-8</a>), determines how quickly bound GTP is hydrolyzed to GDP and thus how long the G protein remains active.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_9QDfMMZh2b" title="hidden">
<p class="noindent" id="dav_9781319322342_oPnEahWcPj">A horizontal piece of membrane has a roughly rectangular protein labeled G P C R that extends across the membrane on the left side. This protein contains a strand that begins outside of the protein and runs vertically down, then up, then down, then slightly to the left as it becomes darker in color, then runs up to the upper right corner, then down to the lower right corner before bending left for a short distance and becoming very pale before running up to form a loop that bends down to the left, bends sharply to the right as it becomes dark and then bends sharply left at the lower center of the rectangular protein, and then leaves the protein at the lower left within a large green oval labeled G subscript s with Greek letter alpha below a gray oval labeled G D P. The large green oval extends to the left from its top side, where a thread extends up halfway through the membrane, and it joins a curved piece labeled Greek letter gamma that wraps back toward the piece labeled G subscript s. Another oval, which is labeled Greek letter beta, is between these two pieces and has a thick tail that extends slightly beneath the right side of the piece labeled G subscript s Greek letter gamma, which curves beneath it. Text above reads, G subscript 2 with G D P bound is turned off; it cannot activate adenylyl cyclase. An arrow points right to a similar structure in which a hexagonal structure with a protrusion to its lower left is shown with an arrow pointing to a similar structure behind the pale loop at the upper right of the large green oval, G subscript s. Text above reads, Contact of G subscript s with hormone-receptor complex causes displacement of bound G D P by G T P. A dashed arrow points from the bottom of this structure back to the starting structure. An arrow points to the right with curved arrows showing a gray oval labeled G D P leaving and an orange oval labeled G T P entering. The product is a single large green G subscript s Greek letter alpha that has bent so that it is now almost vertical. The other two green pieces are not present. A protrusion from the upper right of G subscript s Greek letter alpha joins with a large square that extends across the membrane with its top half divided vertically into two halves and labeled adenylyl cyclase. Short arrows radiate out from all sides of adenylyl cyclase and the large green oval labeled Greek letter alpha. Text above reads, G subscript 2 with G T P bound dissociates into Greek letter alpha and Greek letter beta Greek letter gamma subunits. G subscript s Greek letter alpha-G T P is turned on; it can activate adenylyl cyclase. A dashed arrow points counter clockwise with a dashed arrow curving away to show P subscript i leaving to a structure in the bottom middle of the illustration that is a faded green oval labeled Greek letter alpha that is bent so that its lower end is slightly to the lower right with a protrusion from its upper left running horizontally along the membrane. It contains a gray circle labeled G D P. A dashed arrow points back from this structure to the starting structure.</p>
</aside>
</section>
<section class="sect2" id="dav_9781319322342_egcbQtN5wo">
<header id="dav_9781319322342_LQhqTetXVT"><h4 class="b-head v3" id="dav_9781319322342_dykR6VlCZF">Cyclic AMP Activates Protein Kinase A</h4></header>
<p class="noindent" id="dav_9781319322342_YoteDte1ZS">Epinephrine exerts its downstream effects through the increase in [cAMP] that results from activation of adenylyl cyclase. Cyclic AMP, the second messenger, allosterically activates <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_ztleZ88xlw"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_eWGYWHpG92" id="dav_9781319322342_oyQvGfwUFu" role="doc-glossref">cAMP-dependent protein kinase, also called protein kinase A or PKA</a></dfn> (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_J0iHLT2Ncj" id="dav_9781319322342_HKGq0WWCm0">Fig. 12-4a</a>, step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_z1xDUjNFry" role="presentation" src="../images/5.png"/>), which catalyzes the phosphorylation of specific Ser or Thr residues of targeted proteins, such as glycogen phosphorylase <i class="semantic-i" id="dav_9781319322342_moR3RZ8x7X">b</i> kinase. The latter enzyme is active when phosphorylated and can begin the process of mobilizing glycogen stores in muscle and liver in anticipation of the need for energy, as signaled by epinephrine.</p>
<p class="indent" id="dav_9781319322342_wTW5KonuOD">The inactive form of PKA has two identical catalytic subunits (C) and two identical regulatory subunits (R) (<strong class="important" id="dav_9781319322342_L5KUwWAMbX"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_GLu7LxDhdk" id="dav_9781319322342_2q3HHTtd8A">Fig. 12-6a</a></strong>). The tetrameric <span class="math" id="dav_9781319322342_oZ4Y3gF2s5" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>R</mtext><mn>2</mn></msub><msub><mtext>C</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper R Subscript 2 Baseline upper C Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0028.png"/></annotation-xml></semantics></math></span> complex is catalytically inactive, because an autoinhibitory domain of each R subunit occupies the substrate-binding cleft of each C subunit. The autoinhibitory domain is an intrinsically disordered region that can fold to fit any of several protein partners. Cyclic AMP is an allosteric activator of PKA. When cAMP binds to the R subunits, they undergo a conformational change that moves the autoinhibitory domain of R out of the catalytic domain of C, and the <span class="math" id="dav_9781319322342_wSromRew6u" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>R</mtext><mn>2</mn></msub><msub><mtext>C</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper R Subscript 2 Baseline upper C Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0029.png"/></annotation-xml></semantics></math></span> complex dissociates to yield two free, catalytically active C subunits. <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_ZVWKvFqPXr" role="presentation" src="../images/nelsonlehnpob8e_PG02.png"/> This same basic mechanism — displacement of an autoinhibitory domain — mediates the allosteric activation of many types of protein kinases by their second messengers (as in <a class="crossref" href="nel_9781319228002_ch12_05.xhtml#dav_9781319322342_9F8l4IDh8W" id="dav_9781319322342_vJVOOmBlrQ">Fig. 12-21</a> and <a class="crossref" href="nel_9781319228002_ch12_06.xhtml#dav_9781319322342_2zp9J7bVHL" id="dav_9781319322342_R8UF1JzfUq">12-29</a>, for example). The structure of the substrate-binding cleft in PKA is the prototype for all known protein kinases (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_GLu7LxDhdk" id="dav_9781319322342_fxGea3DT3X">Fig. 12-6b</a>); certain residues in this cleft region have identical counterparts in all of the 544 protein kinases encoded in the human genome. The ATP-binding site of each catalytic subunit positions ATP perfectly for the transfer of its <span aria-label="414" epub:type="pagebreak" id="page414" role="doc-pagebreak"/>terminal <span class="math" id="dav_9781319322342_qqEBamxd9A" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><mi>γ</mi><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis gamma right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0030.png"/></annotation-xml></semantics></math></span> phosphoryl group to the <span class="math" id="dav_9781319322342_PsFQdqAQjm" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mn>—</mn><mtext>OH</mtext></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="em-dash OH" src="../images/MATH/nel_9781319228002_ch12_03EQ_0031.png"/></annotation-xml></semantics></math></span> in the side chain of a Ser or Thr residue in the target protein.</p>
<figure class="figure lm_img_lightbox num c4 center" id="dav_9781319322342_GLu7LxDhdk">
<img alt="A two-part figure shows how the regulatory and catalytic subunits in c A M P-dependent protein kinase change position with changes in c A M P concentration in part a and shows the crystal structure of joined C and R subunits in part b." aria-describedby="dav_9781319322342_tb4fLKWAVZ" class="figure" id="dav_9781319322342_ihS3Z03S5e" src="../images/nelsonlehnpob8e_12_06_301710.png"/>
<figcaption id="dav_9781319322342_LVFTamrqAk">
<p class="noindent" id="dav_9781319322342_2nagRfv7qc"><span class="label" epub:type="label" id="dav_9781319322342_jPApS8acqN">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_WilFakFawY">12-6 </span><span class="title" id="dav_9781319322342_FMhsRvGbLk">Activation of cAMP-dependent protein kinase (PKA). </span>(a) When [cAMP] is low, the two identical regulatory subunits (R; red) associate with the two identical catalytic subunits (C; blue). In this <span class="math" id="dav_9781319322342_5w2svwVQBB" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>R</mtext><mn>2</mn></msub><msub><mtext>C</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper R Subscript 2 Baseline upper C Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0032.png"/></annotation-xml></semantics></math></span> complex, the inhibitor sequences of the R subunits lie in the substrate-binding cleft of the C subunits and prevent binding of protein substrates; the complex is therefore catalytically inactive. The amino-terminal sequences of the R subunits interact to form an <span class="math" id="dav_9781319322342_MPznXjB5G6" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>R</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper R Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0033.png"/></annotation-xml></semantics></math></span> dimer, the site of binding to an A kinase anchoring protein (AKAP; <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_nRuyq7XrmX" id="dav_9781319322342_9Ua1668H7W">Fig. 12-11</a>). When [cAMP] rises in response to a hormonal signal, each R subunit binds two cAMP molecules and undergoes a dramatic reorganization that pulls its inhibitory sequence away from the C subunit, opening up the substrate-binding cleft and releasing each C subunit in its catalytically active form. (b) A crystal structure showing part of the <span class="math" id="dav_9781319322342_1y0Fh0QsJe" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>R</mtext><mn>2</mn></msub><msub><mtext>C</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper R Subscript 2 Baseline upper C Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0034.png"/></annotation-xml></semantics></math></span> complex — one C subunit and part of one R subunit. The amino-terminal dimerization region of the R subunit is omitted for simplicity. The small lobe of C contains the ATP-binding site, and the large lobe surrounds and defines the cleft where the protein substrate binds and undergoes phosphorylation at a Ser or Thr residue, with a phosphoryl group transferred from ATP. In this inactive form, the inhibitor sequence of R blocks the substrate-binding cleft of C, inactivating it. [(b) Data from PDB ID 3FHI, C. Kim et al., <i class="semantic-i" id="dav_9781319322342_Zp9vMqNt57">Science</i> 307:690, 2005.]</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_tb4fLKWAVZ" title="hidden">
<p class="noindent" id="dav_9781319322342_XOif9NptFx">Part a shows a green rounded structure labeled A K A P with pointed protrusions to the upper left and right. The pointed protrusions have a different texture to a horse-shoe shaped region that opens downward. Two threads begin in the open central region surrounded by this horseshoe and run down diagonally in opposite directions, crossing each other near the base of the horseshoe in the dimerization domain. The left-hand thread runs almost horizontally to the left, then almost vertically downward to curve slightly to the right at its end. A blue sphere labeled C and catalytic subunit has an opening on one side labeled substrate-binding cleft that encloses the middle of the vertical portion of the left-hand thread. A red sphere labeled R and regulatory subunit is on the inner side of the bottom of the red sphere labeled R. The right-hand thread is similar except that it extends horizontally to the right and then extends vertically down before curving slightly to the left. This thread is labeled inhibitor sequence. It also runs through a cleft in a blue sphere and has a red sphere over its bottom portion. A downward arrow shows the addition of 4 c A M P, shown as four purple molecules that resemble a rectangle with a triangle on top. An upward arrow shows that the reaction is reversible with the removal of 4 c A M P. The reaction yields a similar green structure with two threads in it that still cross and emerge beneath, but both now angle downward instead of running horizontally. The left-hand thread runs down to almost the middle of the left-hand red sphere, then bends up with a c A M P at the inflection point and a second c A M P along the upward piece before it folds back down to curve to the right on the underside of the red sphere. The blue sphere is now to the left with short lines radiating from all sides and text reading, substrate-binding cleft now available. The right-hand thread runs down to almost the middle of the right-hand red sphere, then curves up to the right with a c A M P at the inflection point and a second c A M P along the upward piece before it folds back down to curve to the left on the underside of the red sphere. The blue sphere is now to the right with short lines radiating from all sides and text reading, substrate-binding cleft now available. Part b shows a blue irregular sphere labeled catalytic (C) subunit that has a rough surface. A smaller irregular red sphere labeled regulatory (R) subunit it to its lower left and also has a rough surface. A brighter piece of red material labeled inhibitor sequence extends from near the lower right of the red sphere almost vertically up to near the top of the blue sphere, separating it into a small piece to the left labeled small lobe (A T P binding) and a large piece to the right labeled large lobe (protein substrate binding).</p>
</aside>
<p class="noindent" id="dav_9781319322342_3IV2GjlfPg">As indicated in <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_J0iHLT2Ncj" id="dav_9781319322342_Secz2p3ku7">Figure 12-4a</a> (step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_DP7kQLHtVy" role="presentation" src="../images/6.png"/>), PKA regulates many enzymes downstream in the signaling pathway. Although these downstream targets have diverse functions, they share a region of sequence similarity around the Ser or Thr residue that undergoes phosphorylation, a sequence that marks them for regulation by PKA. The substrate-binding cleft of PKA recognizes these sequences and phosphorylates their Thr or Ser residue. Comparison of the sequences of various protein substrates for PKA has yielded the short <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_ATo7EkQC81"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_2V0eWxUqpO" id="dav_9781319322342_YgleGjcjMk" role="doc-glossref">consensus <span aria-label="415" epub:type="pagebreak" id="page415" role="doc-pagebreak"/>sequence</a></dfn> in which the target for phosphorylation (Ser or Thr) is most commonly embedded. For PKA, the consensus sequence is xR[RK]x[ST]B, where x can be any residue, R is Arg, [RK] can be either Arg or Lys, [ST] is either Ser or Thr (which is the residue phosphorylated), and B is any basic residue. The consensus sequences of a number of protein kinases are shown in <a class="crossref" href="nel_9781319228002_ch06_06.xhtml#dav_9781319322342_eVhLzkowDS" id="dav_9781319322342_kFz8tNbaLv">Table 6-10</a>; they define the targets of the hundreds of protein kinases in the eukaryotic cell.</p>
<p class="indent" id="dav_9781319322342_crURgzqEui">How do we know that two proteins interact, or where in the cell they interact? Changes in the state of association of two proteins (such as the R and C subunits of PKA) can be seen by measuring the nonradiative transfer of energy between fluorescent probes attached to each protein, a technique called fluorescence resonance energy transfer (FRET), which we describe in <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_8XhbOvUQeq" id="dav_9781319322342_91L2IW3te6">Box 12-1</a>.</p>
<aside class="case-study c3 main-flow v3" epub:type="case-study" id="dav_9781319322342_8XhbOvUQeq">
<header id="dav_9781319322342_Jgrcp7W4yH"><h5 class="title v3 cap" epub:type="title" id="dav_9781319322342_t7o3KTt6Z6">Box 12-1</h5>
<p class="subtitle" epub:type="subtitle" id="dav_9781319322342_kiweXOKiCk" role="doc-subtitle">FRET: Biochemistry in a Living Cell</p></header>
<p class="noindent" id="dav_9781319322342_ea0D9t98db">Fluorescent probes are commonly used to detect biochemical changes in single living cells on a nanosecond time scale. In one widely used procedure, <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_zyu7dA8N0u"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_fagIsua36n" id="dav_9781319322342_CoqHG0jMPa" role="doc-glossref">green fluorescent protein (GFP)</a></dfn> and variants with different fluorescence spectra, described in <a class="crossref" href="nel_9781319228002_ch09_01.xhtml#dav_9781319322342_iNKSWEBZuH" id="dav_9781319322342_Xd1N2THkuR">Chapter 9</a> (see <a class="crossref" href="nel_9781319228002_ch09_03.xhtml#dav_9781319322342_t52oyQb8vG" id="dav_9781319322342_jUso6lnZBW">Fig. 9-16</a>), are genetically fused with another protein. These fluorescent hybrid proteins act as spectroscopic rulers for measuring distances between interacting proteins within a cell. They can be used indirectly as measures of local concentrations of compounds that change the distance between two proteins.</p>
<p class="indent" id="dav_9781319322342_fwSIiqjSxI">An excited fluorescent molecule such as GFP or YFP (yellow fluorescent protein) can dispose of the energy from the absorbed photon in either of two ways: (1) by fluorescence, emitting a photon of slightly longer wavelength (lower energy) than the exciting light, or (2) by nonradiative <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_JXSDOW7hEU"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_2GbBmKmAF9" id="dav_9781319322342_toSILhvBaV" role="doc-glossref">fluorescence resonance energy transfer (FRET)</a></dfn>, in which the energy of the excited molecule (the donor) passes directly to a nearby molecule (the acceptor) <i class="semantic-i" id="dav_9781319322342_dULtu0VT4c">without emission of a photon</i>, exciting the acceptor (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_uiib4oMZJn" id="dav_9781319322342_9onmIVBpaK">Fig. 1</a>). The acceptor can now decay to its ground state by fluorescence; the emitted photon has a longer wavelength (lower energy) than both the original exciting light and the fluorescence emission of the donor. This second mode of decay (FRET) is possible only when donor and acceptor are close to each other (within 1 to 50 Å); the efficiency of FRET is inversely proportional to the <i class="semantic-i" id="dav_9781319322342_NGUg3rdKwA">sixth power</i> of the distance between donor and acceptor. Thus, very small changes in the distance between donor and acceptor register as very large changes in FRET, measured as the fluorescence of the acceptor molecule when the donor is excited. With sufficiently sensitive light detectors, this fluorescence signal can be located to specific regions of a single, living cell.</p>
<figure class="figure lm_img_lightbox num c5 center" id="dav_9781319322342_uiib4oMZJn">
<img alt="A figure shows how genetically engineered C F P and Y F P proteins interact to allow fluorescence resonance energy transfer (F R A T)." aria-describedby="dav_9781319322342_ohyHzpphjv" class="figure" id="dav_9781319322342_ANM1lEA6zq" src="../images/nelsonlehnpob8e_12_box0101_301750.png"/>
<figcaption id="dav_9781319322342_gG0ZH6A40C">
<p class="noindent" id="dav_9781319322342_nKX4hqGLRU"><span class="label" epub:type="label" id="dav_9781319322342_IcfnJAutuY">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_qGKFUoRS4y">1 </span>When the donor protein (CFP) is excited with monochromatic light of wavelength 433 nm, it emits fluorescent light at 476 nm (left). When the (red) protein fused with CFP interacts with the (purple) protein fused with YFP, that interaction brings CFP and YFP close enough to allow fluorescence resonance energy transfer (FRET) between them. Now, when CFP absorbs light of 433 nm, instead of fluorescing at 476 nm, it transfers energy directly to YFP, which then fluoresces at its characteristic emission wavelength, 527 nm. The ratio of light emission at 527 nm and 476 nm is therefore a measure of the extent of interaction between the red and purple proteins.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_ohyHzpphjv" title="hidden">
<p class="noindent" id="dav_9781319322342_xoOfhE0dPG">A light red sphere has a short thread extending up that curves slightly to the right and then back to end at the bottom of a light blue protein labeled C F P that resembles a coiled snail shell. A wavy arrow labeled 433 n m points to the C F P protein and a light blue highlighted wavy arrow labeled 476 n m points away from the light blue C F P protein. A purple sphere with a thread extending up is similar to the light red sphere has a similar thread and joins to the bottom of an orange protein labeled Y F P. Both of these structures are labeled genetically engineered hybrid proteins. An arrow pointing right is labeled protein-protein interaction. The two structures are shown lined up together, with the right side of the light red sphere touching the left side of the purple sphere and the right side of the light blue C F P protein touching the left side of the orange Y F P protein. A wavy arrow labeled 433 n m points to the light blue C F P protein and a yellow highlighted wavy arrow labeled 527 n m points away from the orange Y F P protein. A dashed curved arrow begins at the light blue C F P protein and curves through a yellow rectangle labeled F R E T to end at the orange Y F P protein.</p>
</aside>
<p class="indent" id="dav_9781319322342_cG9BLgARKt">FRET has been used to measure [cAMP] in living cells. The gene for BFP (blue fluorescent protein) is fused with that for the regulatory subunit (R) of cAMP-dependent protein kinase (PKA), and the gene for GFP is fused with that for the catalytic subunit (C) (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_0sqvwZxaaJ" id="dav_9781319322342_9nhT60d8nU">Fig. 2</a>). When these two hybrid proteins are expressed in a cell, BFP (donor) and GFP (acceptor) in the inactive PKA (<span class="math" id="dav_9781319322342_KMJz1Cs5YP" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>R</mtext><mn>2</mn></msub><msub><mtext>C</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper R Subscript 2 Baseline upper C Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0035.png"/></annotation-xml></semantics></math></span> tetramer) are close enough to undergo FRET. Wherever in the cell [cAMP] increases, the <span class="math" id="dav_9781319322342_XdCXVhHwvT" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>R</mtext><mn>2</mn></msub><msub><mtext>C</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper R Subscript 2 Baseline upper C Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0036.png"/></annotation-xml></semantics></math></span> complex dissociates into <span class="math" id="dav_9781319322342_p77qWJHvIQ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>R</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper R Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0037.png"/></annotation-xml></semantics></math></span> and 2 C and the FRET signal is lost, because donor and acceptor are now too far apart for efficient FRET. Viewed in the fluorescence microscope, the region of higher [cAMP] has a minimal GFP signal and higher BFP signal. Measuring the ratio of emission at 460 nm and 545 nm gives a sensitive measure of the change in [cAMP]. By determining this ratio for all regions of the cell, the investigator can generate a false color image of the cell in which the ratio, or relative [cAMP], is represented by the intensity of the color. Images recorded at timed intervals reveal changes in [cAMP] over time.</p>
<figure class="figure lm_img_lightbox num c5 center" id="dav_9781319322342_0sqvwZxaaJ">
<img alt="A figure shows how c A M P concentration can be measured by using hybrid proteins that exhibit F R E T when the P K A regulatory and catalytic subunits are associated at low concentrations of c A M P but that do not exhibit F R E T when these subunits are not associated at high concentrations of c A M P." aria-describedby="dav_9781319322342_kfwTOrHmGA" class="figure" id="dav_9781319322342_o4tu5vkUxp" src="../images/nelsonlehnpob8e_12_box0102_301751.png"/>
<figcaption id="dav_9781319322342_Shc44cfSdR">
<p class="noindent" id="dav_9781319322342_uwWHo5nH0w"><span class="label" epub:type="label" id="dav_9781319322342_j7Vm4VecU0">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_YmyTxjPV1T">2 </span>Measuring [cAMP] with FRET. Gene fusion creates hybrid proteins that exhibit FRET when the PKA regulatory (R) and catalytic (C) subunits are associated (low [cAMP]). When [cAMP] rises, the subunits dissociate and FRET ceases. The ratio of emission at 460 nm (dissociated) and 545 nm (complexed) thus offers a sensitive measure of [cAMP].</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_kfwTOrHmGA" title="hidden">
<p class="noindent" id="dav_9781319322342_HdtBFlVqzJ">The top structure is labeled c A M P-dependent protein kinase (P K A). It has crossed red threads at the top. The left-hand thread runs horizontally to the left, then vertically down through a cleft in a blue sphere labeled C to end by curving to the right under a red sphere labeled R. A green snail shell-shaped protein to its left has a long green thread that curves behind the blue sphere. A light blue thread emerges from the lower left of the red sphere labeled R and ends at a light blue snail shell-shaped protein. The right-hand thread runs horizontally to the right, then vertically down through a cleft in a blue sphere labeled C to end by curving to the left under a red sphere labeled R. A green snail shell-shaped protein to its right labeled G F P has a long green thread that curves behind the blue sphere. A green highlighted wavy arrow pointing away from the green G F P protein is labeled 545 n m. A light blue thread emerges from the lower right of the red sphere labeled R and ends at a light blue snail shell-shaped protein labeled B F P. A wavy arrow labeled 380 n m points to the light blue B F P protein. A dashed curved arrow leaves the light blue B F P protein and runs through a yellow rectangle labeled F R E T to point at the green G F P protein. Text below reads, (inactive). A downward arrow is joined by an arrow from four purple structures resembling rectangles with triangles on top labeled c A M P. An upward arrow shows that the reaction is reversible with the loss of c A M P. The product has two red threads crossed near the top. The left-hand thread runs almost diagonally down to almost the middle of the left-hand red sphere, then bends up with a c A M P at the inflection point and a second c A M P along the upward piece before it folds back down to curve to the right on the underside of the red sphere. The light blue snail shell-shaped protein is to the upper left of the red sphere with a light blue thread running to the lower left of the red sphere. The right-hand thread runs almost diagonally down to almost the middle of the right-hand red sphere, then bends up with a c A M P at the inflection point and a second c A M P along the upward piece before it folds back down to curve to the left on the underside of the red sphere. The light blue snail shell-shaped protein is to the upper right of the red sphere with a light blue thread running to the lower right of the red sphere. A wavy arrow pointing to the light blue protein is labeled 380 n m. A blue highlighted wavy arrow pointing away from the light blue protein is labeled 460 n m. Text below reads, active.</p>
</aside>
<p class="indent" id="dav_9781319322342_yCxMsIyDJE">A variation of this technology has been used to measure the activity of PKA in a living cell (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_tEcBkfympB" id="dav_9781319322342_Q1fHLEaB7d">Fig. 3</a>). Researchers create a phosphorylation target for PKA by producing a hybrid protein containing four elements: YFP (acceptor); a short peptide with a Ser residue surrounded by the consensus sequence for PKA; <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_Ns6UTlswNM" role="presentation" src="../images/nelsonlehnpob8e_13_PG_484a.png"/>–Ser-binding domain (called 14-3-3); and CFP (donor). When the Ser residue is not phosphorylated, 14-3-3 has no affinity for the Ser residue and the hybrid protein exists in an extended form, with the donor and acceptor too far apart to generate a FRET signal. Wherever PKA is active in the cell, it phosphorylates the Ser residue of the hybrid protein, and 14-3-3 binds to the <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_YYWSUhhk1F" role="presentation" src="../images/nelsonlehnpob8e_13_PG_484a.png"/>–Ser. In doing so, it draws YFP and CFP together and a FRET signal is detected with the fluorescence microscope, revealing the presence of active PKA.</p>
<figure class="figure lm_img_lightbox num c5 center" id="dav_9781319322342_tEcBkfympB">
<img alt="A figure shows the structures of two types of signal-transducing guanylyl cyclase with part a showing an A N F receptor and an example of a guanylin and endotoxin receptor as examples of membrane-spanning guanylyl cyclases and part b showing a soluble N O-activated guanylyl cyclase." aria-describedby="dav_9781319322342_qCDPTJudva" class="figure" id="dav_9781319322342_KTSVvG6dtH" src="../images/nelsonlehnpob8e_12_box0103_301752.png"/>
<figcaption id="dav_9781319322342_PBpxfrEXn3">
<p class="noindent" id="dav_9781319322342_Xqa1kJQ4ad"><span class="label" epub:type="label" id="dav_9781319322342_nGHMBFFAWO">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_LDrUprOeVs">3 </span>Measuring the activity of PKA with FRET. An engineered protein links YFP and CFP via a peptide that contains (1) a Ser residue surrounded by the consensus sequence for phosphorylation by PKA and (2) the 14-3-3 <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_aazVeTjqbm" role="presentation" src="../images/nelsonlehnpob8e_13_PG_484a.png"/>–Ser-binding domain. Active PKA phosphorylates the Ser residue, which docks with the 14-3-3 binding domain, bringing the fluorescence proteins close enough to allow FRET, revealing the presence of active PKA.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_qCDPTJudva" title="hidden">
<p class="noindent" id="dav_9781319322342_lEA8STzPbt">A horizontal piece of membrane shows the extracellular ligand-binding (receptor) domains of two receptors above the membrane and the intracellular catalytic (c G M P-forming) domains below the membrane. Part a is labeled membrane-spanning guanylyl cyclases. The left-hand structure is labeled A N F receptor. It has two light red rectangles above the membrane that each bend slightly toward the center, so they meet on top and are separate at the bottom. A green diamond labeled A N F is between them just below the midpoint of the structure. Each has a blue vertical line that extends down across the membrane. These blue lines each form a sphere beneath the membrane with short lines radiating from all sides. G T P is shown with a curved line running through the bottom of the right-hand blue circle to c G M P. The right-hand molecule is labeled guanylin and endotoxin receptors. It has a similar structure, except that the two light red halves each have cutouts to form a diamond-shaped opening just below the midpoint labeled ligand-binding site. Part b is labeled soluble N O-activated guanylyl cyclase. It shows a blue circle containing a light red diamond labeled F e inside the circle with its right side vertex joined to the right side of the circle. This light red diamond is labeled heme.</p>
</aside>
<p class="indent" id="dav_9781319322342_ubIhDMHl7h">With more sophisticated microscopic equipment, the FRET signal from a single protein molecule can be detected with much higher spatial and temporal resolution than is available in FRET with an ensemble of molecules.</p>
</aside>
<p class="indent" id="dav_9781319322342_WOZaYJAbAg"><span aria-label="416" epub:type="pagebreak" id="page416" role="doc-pagebreak"/><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_wbjkH690DV" role="presentation" src="../images/nelsonlehnpob8e_PG01a.png"/> As in many signaling pathways, signal transduction by the <i class="semantic-i" id="dav_9781319322342_U3PisOtVLH">β</i>-adrenergic receptor and adenylyl cyclase entails several steps that <i class="semantic-i" id="dav_9781319322342_CJFNO6e0KI">amplify</i> the original hormone signal (<strong class="important" id="dav_9781319322342_TXPvwSsXa6"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_zrCdnAelAA" id="dav_9781319322342_chhMXszghJ">Fig. 12-7</a></strong>). First, the binding of one hormone molecule to one receptor molecule catalytically activates many <span class="math" id="dav_9781319322342_Pe0ten656a" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0038.png"/></annotation-xml></semantics></math></span> molecules that associate with the activated receptor, one after the other. Next, by activating one molecule of adenylyl cyclase, each active <span class="math" id="dav_9781319322342_rIPuCwNTm9" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0039.png"/></annotation-xml></semantics></math></span> molecule stimulates the catalytic synthesis of <i class="semantic-i" id="dav_9781319322342_W5le4U1sqV">many</i> molecules of cAMP. The second messenger cAMP now activates PKA, each molecule of which catalyzes the phosphorylation of <i class="semantic-i" id="dav_9781319322342_6xjBtexWQI">many</i> molecules of the target protein — phosphorylase <i class="semantic-i" id="dav_9781319322342_mWrze41nK0">b</i> kinase in <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_zrCdnAelAA" id="dav_9781319322342_efuImjslYT">Figure 12-7</a>. This kinase activates glycogen phosphorylase <i class="semantic-i" id="dav_9781319322342_WeeKDuZOBX">b</i>, which leads to the rapid mobilization of glucose from glycogen. The net effect of the cascade is amplification of the hormonal signal by orders of magnitude, which accounts for the very low concentration of epinephrine (or any other hormone) required for hormone activity. This signaling pathway is also rapid: the signal leads to intracellular changes within fractions of a second.</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_zrCdnAelAA">
<img alt="A figure shows the series of reactions that makes up the epinephrine cascade, in which a molecule of epinephrine starts a process that results in 100,000 molecules of blood glucose." aria-describedby="dav_9781319322342_L2OjtPMtLe" class="figure" id="dav_9781319322342_tdhZhqDaOJ" src="../images/nelsonlehnpob8e_12_07_301711.png"/>
<figcaption id="dav_9781319322342_lMxxmHhhvk">
<p class="noindent" id="dav_9781319322342_EMmn1ndRUm"><span class="label" epub:type="label" id="dav_9781319322342_FGkYZiwP3M">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_qozsbmuFrf">12-7 </span><span class="title" id="dav_9781319322342_SxqPvhruyu">Epinephrine cascade.</span> Epinephrine triggers a series of reactions in hepatocytes in which catalysts activate catalysts, resulting in great amplification of the original hormone signal. The numbers of molecules shown are simply to illustrate amplification and are almost certainly gross underestimates. Binding of one molecule of epinephrine to one <i class="semantic-i" id="dav_9781319322342_NlQ2De187D">β</i>-adrenergic receptor on the cell surface activates many (possibly hundreds of) G proteins, one after another, each of which goes on to activate a molecule of the enzyme adenylyl cyclase. Adenylyl cyclase acts catalytically, producing many molecules of cAMP for each activated adenylyl cyclase. (Because two molecules of cAMP are required to activate one PKA catalytic subunit, this step does not amplify the signal.)</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_L2OjtPMtLe" title="hidden">
<p class="noindent" id="dav_9781319322342_s7Ze3IQ53i">A small hexagonal molecule with a protrusion to the upper left is labeled epinephrine and is next to a rectangle labeled 1 molecule. An arrow points down to show the same molecule in a rectangle that extends across the membrane of a hepatocyte and that has a green oval below that curves to the upper left, where it protrudes into the membrane and meets a crescent-shaped green piece with a protrusion into the membrane that wraps around a green oval between it and the larger oval. The receptor with the bound epinephrine is labeled epinephrine-receptor complex with an adjacent rectangle labeled 1 molecule. A dashed arrow points right from the large green oval to a similar green oval that is almost vertical with a protrusion into the membrane, short lines radiating from all sides, and an adjacent rectangle labeled 10 molecules. A dashed arrow points diagonally down to the left to a green circle enclosing a green triangle above an arrow pointing from A T P to cyclic A T P and labeled blue highlighted adenylyl cyclase. An adjacent rectangle is labeled 200 molecules. An arrow points down to the lower left join an arrow from inactive P K A to active P K A. An adjacent rectangle is labeled 100 molecules. A dashed arrow points down to the lower left to a green circle enclosing a green triangle above an arrow that points from inactive phosphorylase italicized b end italics kinase to active phosphorylase italicized b end italics kinase. An adjacent rectangle is labeled 1,000 molecules. A dashed arrow points down to the lower left to a green circle enclosing a green triangle above and arrow that points from inactive glycogen phosphorylase italicized b end italics to active glycogen phosphorylase italicized a end italics. An adjacent rectangle is labeled 10,000 molecules. A dashed arrow points down to the lower left to a green circle enclosing a green triangle above and arrow that points from glycogen to active glucose 1-phosphate. An adjacent rectangle is labeled 100,000 molecules. An arrow points down to glucose, from which an arrow points out of the cell to blood glucose. An adjacent rectangle is labeled 100,000 molecules.</p>
</aside>
</section>
<section class="sect2" id="dav_9781319322342_rCR9zF87ox">
<header id="dav_9781319322342_VW8n4pjGVf"><h4 class="b-head v3" id="dav_9781319322342_4xiTBgWbyv">Several Mechanisms Cause Termination of the <i class="semantic-i" id="dav_9781319322342_XvFoMILfjo">β</i>-Adrenergic Response</h4></header>
<p class="noindent" id="dav_9781319322342_hfFNT6zbKd"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_ZJJnOtTy7S" role="presentation" src="../images/nelsonlehnpob8e_PG01a.png"/> To be useful, a signal-transducing system has to <i class="semantic-i" id="dav_9781319322342_ix8s9ZQjbV">turn off</i> after the hormonal or other stimulus has ended, and mechanisms for shutting off the signal are part of all signaling systems. Most systems also adapt to the continued presence of the signal by becoming less sensitive to <span aria-label="417" epub:type="pagebreak" id="page417" role="doc-pagebreak"/>it, by <i class="semantic-i" id="dav_9781319322342_eDX6yor4z5">desensitizing</i>. The <i class="semantic-i" id="dav_9781319322342_gk1U6NlS9S">β</i>-adrenergic system illustrates both. Here, our focus is on termination.</p>
<p class="indent" id="dav_9781319322342_oNH1FkGNeu">The response to <i class="semantic-i" id="dav_9781319322342_PPAozVmcoZ">β</i>-adrenergic stimulation will end when the concentration of the ligand (epinephrine) in the blood drops below the <span class="math" id="dav_9781319322342_BoyBcy6NWW" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>K</mi><mtext>d</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper K Subscript d" src="../images/MATH/nel_9781319228002_ch12_03EQ_0040.png"/></annotation-xml></semantics></math></span> for its receptor. The epinephrine then dissociates from the receptor, and the latter reassumes its inactive conformation, in which it can no longer activate <span class="math" id="dav_9781319322342_dyJS61ww1O" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0041.png"/></annotation-xml></semantics></math></span>.</p>
<p class="indent" id="dav_9781319322342_ieqFP0jcVL">A second means of ending the response is the hydrolysis of GTP bound to the <span class="math" id="dav_9781319322342_0J3KRzOFoH" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mi>α</mi></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0042.png"/></annotation-xml></semantics></math></span> subunit, catalyzed by the GTPase activity of the G protein. Conversion of bound GTP to GDP favors the return of <span class="math" id="dav_9781319322342_OsrRQQGhR7" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mi>α</mi></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0043.png"/></annotation-xml></semantics></math></span> to the conformation in which it binds the <span class="math" id="dav_9781319322342_ZqLahWysmL" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mi>β</mi><mi>γ</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript beta gamma" src="../images/MATH/nel_9781319228002_ch12_03EQ_0044.png"/></annotation-xml></semantics></math></span> subunits — the conformation in which the G protein is unable to interact with or stimulate adenylyl cyclase. This ends the production of cAMP. The rate of inactivation of <span class="math" id="dav_9781319322342_OtsLv45zB6" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0045.png"/></annotation-xml></semantics></math></span> depends on the GTPase activity, which for <span class="math" id="dav_9781319322342_MqHTApn8oz" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mi>α</mi></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0046.png"/></annotation-xml></semantics></math></span> alone is very feeble. However, <strong class="important" id="dav_9781319322342_UCUol9xt3u">GTPase activator proteins (GAPs)</strong> strongly stimulate this GTPase activity, causing more-rapid inactivation of the G protein (<strong class="important" id="dav_9781319322342_BVTdsUAgWm"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_pzaM52Svls" id="dav_9781319322342_lHgkU8jr9s">Fig. 12-8</a></strong>). GAPs can themselves be regulated by other factors, providing a fine-tuning of the response to <i class="semantic-i" id="dav_9781319322342_9ZEmqM9DZV">β</i>-adrenergic stimulation. A third mechanism for terminating the response is to remove the second messenger: cAMP is hydrolyzed to <span class="math" id="dav_9781319322342_7b6G5q631f" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mn>5</mn><mo>′</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="5 prime" src="../images/MATH/nel_9781319228002_ch12_03EQ_0047.png"/></annotation-xml></semantics></math></span>-AMP (which is not active as a second messenger) by <strong class="important" id="dav_9781319322342_oHMCNNW93N">cyclic nucleotide phosphodiesterase</strong> (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_J0iHLT2Ncj" id="dav_9781319322342_qFTaVcR6mf">Fig. 12-4a</a>, step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_lwQBPJa9P4" role="presentation" src="../images/7.png"/>; <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_J0iHLT2Ncj" id="dav_9781319322342_BP0uD1NB9d">12-4b</a>).</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_pzaM52Svls">
<img alt="A figure shows how G-protein activity is regulated by G T P-G D P exchange factors and modulators of G T Pase activity of G proteins such as G A Ps and R G Ss." aria-describedby="dav_9781319322342_HkEbAxRvtc" class="figure" id="dav_9781319322342_8AhlurqLnE" src="../images/nelsonlehnpob8e_12_08_301712.png"/>
<figcaption id="dav_9781319322342_cnUzLafZ7t">
<p class="noindent" id="dav_9781319322342_ZPxJpmWE6n"><span class="label" epub:type="label" id="dav_9781319322342_qfnXvB8ezM">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_bCO5ACebAu">12-8 </span><span class="title" id="dav_9781319322342_mtXs3SC7vH">Factors that regulate G-protein activity.</span> Inactive G proteins, both small G proteins such as Ras and heterotrimeric G proteins such as <span class="math" id="dav_9781319322342_5leANxzxEJ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0048.png"/></annotation-xml></semantics></math></span>, interact with upstream GTP-GDP exchange factors (red). Often these exchange factors are activated (*) receptors such as rhodopsin (Rh) and <i class="semantic-i" id="dav_9781319322342_BAZVRXB2Jn">β</i>-adrenergic receptors (AR). The G proteins are activated by GTP binding, and in the GTP-bound form, activate downstream effector enzymes (blue), such as cGMP phosphodiesterase (PDE), adenylyl cyclase (AC), and Raf. By modulating the GTPase activity of G proteins, GTPase activator proteins (GAPs, in the case of small G proteins) and regulators of G-protein signaling (RGSs) (yellow), determine how long the G protein will remain active.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_HkEbAxRvtc" title="hidden">
<p class="noindent" id="dav_9781319322342_zBisgpXORD">A green oval labeled G protein (inactive) has a horizontal protrusion to the upper left from which a thread extends upward and has a gray oval labeled G D P. An arrow pointing to the right has an arrow pointing away to show the loss of the G D P and is joined by an arrow from an orange oval labeled G T P. The G T P is attached to the right side of a vertical rectangle labeled R h asterisk, Greek letter beta-A R asterisk, etc. Text above the rectangle reads, G T P-G D P exchange factors (G E Fs). This produces an almost vertical green oval labeled G protein (active) with a small protrusion from its upper right, a thread extending upward, an orange oval labeled G T P, and short radiating lines all around it. Two arrows point away from this green oval. One arrow points to a rectangle with a vertical rectangle with rounded edges attached to its right side and labeled, c G M P P D E, A C, R a f, etc. Text below reads, Downstream effector enzymes. The second arrow curves clockwise above a yellow oval labeled G A P, R G S, etc. above text reading, Modulators of G T Pase activity. The arrow continues and splits to an arrow showing that P subscript I is lost and an arrow to the starting green oval labeled G protein (inactive).</p>
</aside>
<p class="indent" id="dav_9781319322342_Ch7rsm3CaF">Finally, at the end of the signaling pathway, the metabolic effects that result from phosphorylation of target enzymes by PKA are reversed by the action of <span aria-label="418" epub:type="pagebreak" id="page418" role="doc-pagebreak"/>phosphoprotein phosphatases, which hydrolyze phosphorylated Tyr, Ser, or Thr residues, releasing inorganic phosphate <span class="math" id="dav_9781319322342_R9YIAkhDzP" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msub><mtext>P</mtext><mtext>i</mtext></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis upper P Subscript i Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0049.png"/></annotation-xml></semantics></math></span>. About 190 genes in the human genome encode phosphoprotein phosphatases, fewer than the number (about 540) that encode protein kinases, reflecting the relative promiscuity of the phosphoprotein phosphatases. A single <strong class="important" id="dav_9781319322342_fED1JAS7e2">phosphoprotein phosphatase</strong> (PP1) dephosphorylates some 200 different phosphoprotein targets, including the <i class="semantic-i" id="dav_9781319322342_AmKGkZNMiO">β</i>-adrenergic receptor and other GPCRs. Some phosphatases are known to be regulated; others may be constantly active. When [cAMP] drops and PKA returns to its inactive form (step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_3OUoUZc9rw" role="presentation" src="../images/7.png"/> in <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_J0iHLT2Ncj" id="dav_9781319322342_ITOCXxeFhr">Fig. 12-4a</a>), the balance between phosphorylation and dephosphorylation is tipped toward dephosphorylation by these phosphatases.</p>
</section>
<section class="sect2" id="dav_9781319322342_3wYIF4ZSYa">
<header id="dav_9781319322342_74Ull0kPHk"><h4 class="b-head v3" id="dav_9781319322342_YjfiTg8Iim">The <i class="semantic-i" id="dav_9781319322342_kH5rk7qLip">β</i>-Adrenergic Receptor Is Desensitized by Phosphorylation and by Association with Arrestin</h4></header>
<p class="noindent" id="dav_9781319322342_AULQYdz2Qx">The mechanisms for signal termination described above take effect when the stimulus ends. A different mechanism, desensitization, damps the response <i class="semantic-i" id="dav_9781319322342_NZyw3kRgoZ">even while the signal persists</i>. When the receptor remains occupied with epinephrine, <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_wRabpZz3BO"><strong class="important" id="dav_9781319322342_986RkE7YTg"><i class="semantic-i" id="dav_9781319322342_hFrl8VJ8XA">β</i></strong>-adrenergic receptor kinase, or <strong class="important" id="dav_9781319322342_PKXTtjka0y"><i class="semantic-i" id="dav_9781319322342_e51CXfshMZ">β</i></strong>ARK</dfn>, phosphorylates several Ser residues near the receptor’s carboxyl terminus, which is on the cytoplasmic side of the plasma membrane (<strong class="important" id="dav_9781319322342_MsWIhqZpC4"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_vBGkg2zUCr" id="dav_9781319322342_Q0FAyZLNXB">Fig. 12-9</a></strong>). <i class="semantic-i" id="dav_9781319322342_TxxVCLepXt">β</i>ARK is drawn to the plasma membrane by its association with the <span class="math" id="dav_9781319322342_21VynWoPbC" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>β</mi><mi>γ</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s beta gamma" src="../images/MATH/nel_9781319228002_ch12_03EQ_0050.png"/></annotation-xml></semantics></math></span> subunits and is thus positioned to phosphorylate the receptor. Receptor phosphorylation creates a binding site for the protein <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_Tv7whN00Dx"><strong class="important" id="dav_9781319322342_4fTLFPvBF6"><i class="semantic-i" id="dav_9781319322342_Ma1JBoEHNc">β</i></strong>-arrestin, or <strong class="important" id="dav_9781319322342_bvcUhY0Bdp"><i class="semantic-i" id="dav_9781319322342_lNmZZnIKs8">β</i></strong>arr</dfn> (also called arrestin 2), and binding of <i class="semantic-i" id="dav_9781319322342_1mJFqj3Yus">β</i>-arrestin blocks the sites in the receptor that interact with the G protein (<strong class="important" id="dav_9781319322342_ITN1W8Dy4g"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_xZA69AcSC6" id="dav_9781319322342_puXQkzoBjO">Fig. 12-10</a></strong>). The binding of <i class="semantic-i" id="dav_9781319322342_guOfKom64y">β</i>-arrestin also facilitates the sequestration of receptor molecules and their removal from the plasma membrane by endocytosis into small intracellular vesicles (endosomes). The arrestin-receptor complex recruits clathrin and other proteins involved in vesicle formation, which initiate membrane invagination, leading to the formation of endosomes containing the adrenergic receptor. In this state, the receptors are inaccessible to epinephrine and <span aria-label="419" epub:type="pagebreak" id="page419" role="doc-pagebreak"/>therefore inactive. These receptor molecules are eventually dephosphorylated and returned to the plasma membrane, completing the circuit and resensitizing the system to epinephrine.</p>
<figure class="figure lm_img_lightbox num c4 center" id="dav_9781319322342_vBGkg2zUCr">
<img alt="A figure shows how the continued process of epinephrine leads to the desensitization of the Greek letter beta adrenergic receptor in 5 steps." aria-describedby="dav_9781319322342_RMBpTpINe9" class="figure" id="dav_9781319322342_kJgMi7ZsUq" src="../images/nelsonlehnpob8e_12_09_301713.png"/>
<figcaption id="dav_9781319322342_u2egMOE8Q8">
<p class="noindent" id="dav_9781319322342_l635lnnd9S"><span class="label" epub:type="label" id="dav_9781319322342_z3ys36OCwd">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_ZtLeD3X082">12-9 </span><span class="title" id="dav_9781319322342_X1E4FNgK0v">Desensitization of the <strong class="important" id="dav_9781319322342_jlSCq13lMf"><i class="semantic-i" id="dav_9781319322342_zCcdJrVp1S">β</i></strong>-adrenergic receptor in the continued presence of epinephrine.</span> This process is mediated by two proteins: <i class="semantic-i" id="dav_9781319322342_0WFHu8Y4nQ">β</i>-adrenergic protein kinase (<i class="semantic-i" id="dav_9781319322342_qDbAtdaInc">β</i>ARK) and <i class="semantic-i" id="dav_9781319322342_zbOs2Uo0UN">β</i>-arrestin (<i class="semantic-i" id="dav_9781319322342_sriH4XgLIR">β</i>arr). Not shown here is the phosphorylation and activation of <i class="semantic-i" id="dav_9781319322342_Cyywpw1bk5">β</i>ARK by PKA. PKA is activated by the rise in [cAMP] in response to the initial signal (epinephrine).</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_RMBpTpINe9" title="hidden">
<p class="noindent" id="dav_9781319322342_kxJ9XyU356">A plasma membrane runs almost horizontally from left to right, with a slight dip on the right side. Step 1: Binding of epinephrine (E) to Greek letter beta-adrenergic receptor triggers dissociation of G subscript s Greek letter beta Greek letter gamma from G subscript s Greek letter alpha (not shown). A light red, roughly rectangular protein extends across the membrane. It contains a thread that begins at the upper right, runs up and down inside, and exits to the lower left. A hexagon labeled E with a protrusion from its lower left side is at the upper left side of the protein. A Greek oval labeled G subscript 2 and Greek letter beta has a small tail beneath that curves to the right and that runs behind the bottom right side of a crescent that has a small tail extending into the membrane from its upper right side. An arrow points to the right. Step 2: G subscript 2 Greek letter beta Greek letter gamma recruits Greek letter beta A R K to the membrane, where it phosphorylates S e r residues at the carboxyl terminus of the receptor. The rectangular protein in the membrane is still present with the molecule labeled E at its upper right. A blue rectangle labeled Greek letter beta uppercase A uppercase R uppercase K is against the bottom of the rectangular protein in the membrane. The thread extending from the lower left of the rectangular protein in the membrane has two circles labeled P extending from it. The green oval labeled G subscript s and Greek letter beta is still next to the green crescent labeled Greek letter gamma, which now has a piece at its middle left that runs slightly behind the blue rectangle labeled Greek letter beta uppercase A uppercase R uppercase K. An arrow points to the right. Step 3: Greek letter beta-arrestin (Greek letter beta a r r) binds to the phosphorylated carboxyl-terminal domain of the receptor. The rectangular protein in the membrane is still present with the molecule labeled E at its upper right. An orange rectangle labeled Greek letter beta lowercase a lowercase r lowercase r is against the bottom of the rectangular protein in the membrane. The thread extending from the lower left of the rectangular protein in the membrane still has two circles labeled P extending from it, but has now bent vertically so that the two circles labeled P are in the rectangle labeled Greek letter beta lowercase a lowercase r lowercase r. The membrane dips down at this point and an arrow points down to the inflection point before it begins to rise again. The rectangle in the membrane with the rectangle labeled Greek letter beta lowercase a lowercase r lowercase r is now in the inflection point. Step 4: Receptor-arrestin complex enters the cell by endocytosis. An arrow points down to an orange rectangle labeled Greek letter beta lowercase a lowercase r lowercase r that is on the outside of a vesicle and attached to a light red, rectangular protein to its left that extends across the membrane of the vesicle. A similar light red, rectangular protein with a thread extending from its top side extends across the membrane at the upper left side of the same vesicle. Step 5: In endocytic vesicle, arrestin dissociates; receptor is dephosphorylated and returned to cell surface.</p>
</aside>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_xZA69AcSC6">
<img alt="A two-part figure shows the structure of a Greek letter beta-adrenergic receptor complexed with a trimeric G protein in part a and with Greek letter beta arrestin in part b to illustrate how arrestin helps to prevent further binding of the G protein." aria-describedby="dav_9781319322342_L2azhh1s4j" class="figure" id="dav_9781319322342_tMgowgpsof" src="../images/nelsonlehnpob8e_12_10_301714.png"/>
<figcaption id="dav_9781319322342_O2787EpY8q">
<p class="noindent" id="dav_9781319322342_cxGO8sL5QS"><span class="label" epub:type="label" id="dav_9781319322342_NpKIg7RUdh">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_I1eqR4r2y4">12-10 </span><span class="title" id="dav_9781319322342_LNjMuvG2QE">Mutual exclusion of trimeric G protein and arrestin in their interaction with a GPCR.</span> (a) The <i class="semantic-i" id="dav_9781319322342_4Uc61YSZrz">β</i>-adrenergic receptor complexed with its trimeric G protein, <span class="math" id="dav_9781319322342_n4lrhKSPwD" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0051.png"/></annotation-xml></semantics></math></span>. (b) Another GPCR, the rhodopsin receptor, phosphorylated near its carboxyl terminus, and bound to arrestin. Binding of arrestin blocks binding and further activation of the G protein and ends the response to the initial signal. [Data from (a) PDB ID 3SN6, S. G. F. Rasmussen et al., <i class="semantic-i" id="dav_9781319322342_Aj6lHzFyNk">Nature</i> 477:549, 2011; (b) PDB ID 4ZWJ, Y. Kang et al., <i class="semantic-i" id="dav_9781319322342_1oE8MopIYs">Nature</i> 523:561, 2015.]</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_L2azhh1s4j" title="hidden">
<p class="noindent" id="dav_9781319322342_dr6MEloqZ1">A horizontal piece of plasma membrane is shown with the area above labeled outside and the area below labeled inside. A roughly rectangular light red molecule labeled Greek letter beta-adrenergic receptor with mostly vertical helices inside extends across the membrane. A yellow molecule is visible near the top center. A bright green structure that resembles a thick rod angled slightly up to the right is beneath the light red protein and extends up higher in the middle than on the left and right sides of the bottom of the light red protein. It contains helices that are mostly horizontal or diagonal. A light green structure on the lower right is rounded and contains beta strands with a helix at the right side connected to a diagonal helix that forms a piece that extends to the lower left. A darker green piece is behind it and extends slightly above with a helix that extends slight above the helix of the light green piece to the lower left. The green structure is labeled trimeric green protein. Part b shows a similar light red protein with a piece labeled rhodopsin at the top. An irregular, roughly circular brown protein labeled arrestin is beneath the light red molecule and is wider to its left side with a thinner piece that extends diagonally up to the membrane to the right of the light red protein. The brown protein contains many beta strands. At the lower right of the light red protein, a strand extends down vertically over the brown molecule. Two red spheres in the center of this vertical piece are accompanied by text reading, phosphorylation here favors arrestin binding.</p>
</aside>
<p class="indent" id="dav_9781319322342_SULH8yZNft"><i class="semantic-i" id="dav_9781319322342_VKqEs8I7EZ">β</i>-Adrenergic receptor kinase is a member of a family of <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_8N44HaSs41"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_DpX51oNht1" id="dav_9781319322342_zyiw9rQ31i" role="doc-glossref">G protein–coupled receptor kinases (GRKs)</a></dfn>, all of which phosphorylate GPCRs on their carboxyl-terminal cytoplasmic domains and play roles similar to that of <i class="semantic-i" id="dav_9781319322342_RONaY2A2U5">β</i>ARK in desensitization and resensitization of their receptors. Seven GRKs and four different arrestins are encoded in the human genome; each GRK is capable of desensitizing a particular subset of GPCRs, and each arrestin can interact with many different types of phosphorylated receptors.</p>
<p class="indent" id="dav_9781319322342_cRmztFqhAx"><img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_g7iOtW2u4A" role="presentation" src="../images/nelsonlehnpob8e_IC_pg_37.png"/> The receptor-arrestin complex has another important role: it initiates signaling by a second pathway, the MAPK cascade described below. Thus, acting through a single GPCR, epinephrine triggers two divergent signaling pathways. The two pathways, one initiated by the receptor’s interaction with a G protein and the other initiated by its interaction with arrestin, can be differentially affected by the agonist; in some cases, one agonist favors the G-protein pathway and another favors the arrestin pathway. This bias is an important consideration in the development of a medication that acts through a GPCR. For example, the most addictive of the opioid drugs of abuse act more strongly through G-protein signaling than through arrestin. An ideal opioid pain medication would act through the branch of the pathway that has therapeutic effects and not through the pathway that leads to addiction. <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_RfGVIUAtFe" role="presentation" src="../images/nelsonlehnpob8e_01_pg36.png"/></p>
</section>
<section class="sect2" id="dav_9781319322342_9q8yoiMiD4">
<header id="dav_9781319322342_B923Ck6ygB"><h4 class="b-head v3" id="dav_9781319322342_AGxTOwK0r9"><span aria-label="420" epub:type="pagebreak" id="page420" role="doc-pagebreak"/>Cyclic AMP Acts as a Second Messenger for Many Regulatory Molecules</h4></header>
<p class="noindent" id="dav_9781319322342_EwbVYpzjZL"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_KjqAzhMcTY" role="presentation" src="../images/nelsonlehnpob8e_PG01b.png"/> Epinephrine is just one of many hormones, growth factors, and other regulatory molecules that act by changing the intracellular [cAMP] and thus the activity of PKA. <strong class="important" id="dav_9781319322342_oBMDe3sOkr"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_jE7HcB2hLX" id="dav_9781319322342_7mr3ZEyHFM">Table 12-3</a></strong> lists a few examples. Glucagon binds to its receptors in the plasma membrane of adipocytes, activating (via a <span class="math" id="dav_9781319322342_lm95rRPxU6" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0052.png"/></annotation-xml></semantics></math></span> protein) adenylyl cyclase. PKA, stimulated by the resulting rise in [cAMP], phosphorylates and activates two proteins critical to the mobilization of the fatty acids of stored fats (see <a class="crossref" href="nel_9781319228002_ch17_02.xhtml#dav_9781319322342_zIWFzSauA4" id="dav_9781319322342_k7G3lDj7gu">Fig. 17-2</a>). Similarly, the peptide hormone ACTH (adrenocorticotropic hormone, also called corticotropin), produced by the anterior pituitary, binds to specific receptors in the adrenal cortex, activating adenylyl cyclase and raising the intracellular [cAMP]. PKA then phosphorylates and activates several of the enzymes required for the synthesis of cortisol and other steroid hormones. In many cell types, the catalytic subunit of PKA can also move into the nucleus, where it phosphorylates the <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_xky8dXrXau">cAMP response element binding protein (CREB)</dfn>, which alters the expression of specific genes regulated by cAMP.</p>
<table class="table sectioned c3 main-flow" id="dav_9781319322342_jE7HcB2hLX">
<caption id="dav_9781319322342_OvtOHzfYiW">
<p class="noindent" id="dav_9781319322342_U01KPAnBs3"><span class="label" epub:type="label" id="dav_9781319322342_ZsXZmfAyqk">TABLE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_aCWSgCrk0d">12-3 </span><span class="title" id="dav_9781319322342_i3eN9TdXsc">Some Signals That Use cAMP as Second Messenger</span></p>
</caption>
<tr id="dav_9781319322342_N1ohxV8311">
<td class="left" id="dav_9781319322342_zh7ylSEI4M">Corticotropin (ACTH)</td>
</tr>
<tr id="dav_9781319322342_JDaOlwNJq2">
<td class="left" id="dav_9781319322342_CcGN6JNeUU">Corticotropin-releasing hormone (CRH)</td>
</tr>
<tr id="dav_9781319322342_4XSydAvg2R">
<td class="left" id="dav_9781319322342_P4sf3KqawB">Dopamine [<span class="math" id="dav_9781319322342_IYdyZWaT1c" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>D</mtext><mn>1</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper D Subscript 1" src="../images/MATH/nel_9781319228002_ch12_03EQ_0053.png"/></annotation-xml></semantics></math></span>, <span class="math" id="dav_9781319322342_EZoKillbbk" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>D</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper D Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0054.png"/></annotation-xml></semantics></math></span>]</td>
</tr>
<tr id="dav_9781319322342_B6g8N7k0kW">
<td class="left" id="dav_9781319322342_TdiTMFjT8Q">Epinephrine (<i class="semantic-i" id="dav_9781319322342_0bOqNpgiwh">β</i>-adrenergic)</td>
</tr>
<tr id="dav_9781319322342_ZOyLzbiFls">
<td class="left" id="dav_9781319322342_cK9FS0h4yd">Follicle-stimulating hormone (FSH)</td>
</tr>
<tr id="dav_9781319322342_C1DUU0SqVX">
<td class="left" id="dav_9781319322342_rB4DxEf6Ta">Glucagon</td>
</tr>
<tr id="dav_9781319322342_Xe7gePBJ7m">
<td class="left" id="dav_9781319322342_HLkSfxLeq9">Histamine <span class="math" id="dav_9781319322342_TrjXBbg6IO" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msub><mtext>H</mtext><mn>2</mn></msub><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket upper H Subscript 2 Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0055.png"/></annotation-xml></semantics></math></span></td>
</tr>
<tr id="dav_9781319322342_lKLXQXtWgE">
<td class="left" id="dav_9781319322342_YIT8PfRLXz">Luteinizing hormone (LH)</td>
</tr>
<tr id="dav_9781319322342_tAgjR5uKfD">
<td class="left" id="dav_9781319322342_95BSAxAXBS">Melanocyte-stimulating hormone (MSH)</td>
</tr>
<tr id="dav_9781319322342_DoxlLK7LHV">
<td class="left" id="dav_9781319322342_U4IIUk41Gk">Odorants (many)</td>
</tr>
<tr id="dav_9781319322342_2jgd4tHA7S">
<td class="left" id="dav_9781319322342_fuJFvEDu8G">Parathyroid hormone</td>
</tr>
<tr id="dav_9781319322342_yjCTiFWsyQ">
<td class="left" id="dav_9781319322342_28QQpUHTQS">Prostaglandins <span class="math" id="dav_9781319322342_D6dogZVDMP" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>E</mtext><mn>1</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper E Subscript 1" src="../images/MATH/nel_9781319228002_ch12_03EQ_0056.png"/></annotation-xml></semantics></math></span>, <span class="math" id="dav_9781319322342_h9tAmjhWuZ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="upper E Subscript 2" display="inline"><semantics><mrow><msub><mtext>E</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper E Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0057.png"/></annotation-xml></semantics></math> </span><span class="math" id="dav_9781319322342_6PCRqGdsQb" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msub><mtext>PGE</mtext><mn>1</mn></msub><mo lspace="0">,</mo><msub><mtext>PGE</mtext><mn>2</mn></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis PGE Subscript 1 Baseline comma PGE Subscript 2 Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0058.png"/></annotation-xml></semantics></math></span></td>
</tr>
<tr id="dav_9781319322342_wjeQD2FNdT">
<td class="left" id="dav_9781319322342_kTfi9tfQ4F">Serotonin <span class="math" id="dav_9781319322342_dlZqln4Wya" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><mn>5</mn><msub><mrow><mtext>-HT</mtext></mrow><mn>1</mn></msub><mo lspace="0">,</mo><mn>5</mn><msub><mrow><mtext>-HT</mtext></mrow><mn>4</mn></msub><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket 5 hyphen HT Subscript 1 Baseline comma 5 hyphen HT Subscript 4 Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0059.png"/></annotation-xml></semantics></math></span></td>
</tr>
<tr id="dav_9781319322342_m2nbSxvcwU">
<td class="left" id="dav_9781319322342_e3jbfN9Tiw">Somatostatin</td>
</tr>
<tr id="dav_9781319322342_0XYKxLUn5P">
<td class="left" id="dav_9781319322342_yjOD6R5DZb">Tastants (sweet, bitter)</td>
</tr>
<tr id="dav_9781319322342_yCTK1JBnL7">
<td class="left" id="dav_9781319322342_OKdBJZEceH">Thyroid-stimulating hormone (TSH)</td>
</tr>
<tr id="dav_9781319322342_cHHhWuOgFX">
<td class="left" id="dav_9781319322342_h5uGyYDNjn">Note: Receptor subtypes in square brackets. Subtypes may have different transduction mechanisms. For example, serotonin is detected in some tissues by receptor subtypes <span class="math" id="dav_9781319322342_K6cxBoFNtH" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mn>5</mn><msub><mrow><mtext>-HT</mtext></mrow><mn>1</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="5 hyphen HT Subscript 1" src="../images/MATH/nel_9781319228002_ch12_03EQ_0060.png"/></annotation-xml></semantics></math></span> and <span class="math" id="dav_9781319322342_NtZSyqvbo6" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mn>5</mn><msub><mrow><mtext>-HT</mtext></mrow><mn>4</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="5 hyphen HT Subscript 4" src="../images/MATH/nel_9781319228002_ch12_03EQ_0061.png"/></annotation-xml></semantics></math></span>, which act through adenylyl cyclase and cAMP, and in other tissues by receptor subtype <span class="math" id="dav_9781319322342_vUinpiP6Dl" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mn>5</mn><msub><mrow><mtext>-HT</mtext></mrow><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="5 hyphen HT Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0062.png"/></annotation-xml></semantics></math></span>, acting through the phospholipase <span class="math" id="dav_9781319322342_VqtqwF5Jg8" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>C-IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper C hyphen IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0063.png"/></annotation-xml></semantics></math></span> mechanism (see <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_tuRGgwp23J" id="dav_9781319322342_pBnxKoGbHH">Table 12-4</a>).</td>
</tr>
</table>
<p class="noindent" id="dav_9781319322342_22ZMspopHS">Some hormones act by <i class="semantic-i" id="dav_9781319322342_88JHmXz9Vt">inhibiting</i> adenylyl cyclase, thus <i class="semantic-i" id="dav_9781319322342_VlvQht7kdB">lowering</i> [cAMP] and <i class="semantic-i" id="dav_9781319322342_cdZvSt0hyH">suppressing</i> protein phosphorylation by PKA. For example, the binding of somatostatin to its receptor in the pancreas leads to activation of an <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_RgBXzQrfLm"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_21BzV9NgfZ" id="dav_9781319322342_o7QOmh6J5y" role="doc-glossref">inhibitory G protein, or <span class="math" id="dav_9781319322342_RDLGguJOpt"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>i</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript i" src="../images/MATH/nel_9781319228002_ch12_03EQ_0064.png"/></annotation-xml></semantics></math></span></a></dfn>, structurally homologous to <span class="math" id="dav_9781319322342_wSbObej8Q0" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0065.png"/></annotation-xml></semantics></math></span>, that inhibits adenylyl cyclase and lowers [cAMP]. In this way, somatostatin inhibits the secretion of several hormones, including glucagon. In adipose tissue, prostaglandin <span class="math" id="dav_9781319322342_Cs9qMEXKIb" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>E</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper E Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0066.png"/></annotation-xml></semantics></math></span> (<span class="math" id="dav_9781319322342_WRLzqN4vgF" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>PGE</mtext></mrow><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="PGE Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0067.png"/></annotation-xml></semantics></math></span>; see <a class="crossref" href="nel_9781319228002_ch10_04.xhtml#dav_9781319322342_qxwmtGtaR3" id="dav_9781319322342_HcpSq5vCcH">Fig. 10-17</a>) inhibits adenylyl cyclase, thus lowering [cAMP] and slowing the mobilization of lipid reserves triggered by epinephrine and glucagon. In certain other tissues, <span class="math" id="dav_9781319322342_yysEwY4Vtb" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>PGE</mtext></mrow><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="PGE Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0068.png"/></annotation-xml></semantics></math></span> stimulates cAMP synthesis: its receptors are coupled to adenylyl cyclase through a stimulatory G protein, <span class="math" id="dav_9781319322342_7zGO6eHbYY" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0069.png"/></annotation-xml></semantics></math></span>. In tissues with <span class="math" id="dav_9781319322342_KnrLTZCQAh" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>α</mi><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="alpha 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0070.png"/></annotation-xml></semantics></math></span>-adrenergic receptors, epinephrine lowers [cAMP]; in this case, the receptors are coupled to adenylyl cyclase through an inhibitory G protein, <span class="math" id="dav_9781319322342_JV7AcYZHC1" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>i</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript i" src="../images/MATH/nel_9781319228002_ch12_03EQ_0071.png"/></annotation-xml></semantics></math></span>. In short, an extracellular signal such as epinephrine or <span class="math" id="dav_9781319322342_jIBE8I6bmL" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>PGE</mtext></mrow><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="PGE Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0072.png"/></annotation-xml></semantics></math></span> can have different effects on different tissues or cell types, depending on three factors: the type of receptor in the tissue, the type of G protein <span class="math" id="dav_9781319322342_YUeOxKGhl7" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msub><mtext>G</mtext><mtext>s</mtext></msub><mtext> </mtext><mtext>or</mtext><mtext> </mtext><msub><mtext>G</mtext><mtext>i</mtext></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis upper G Subscript s Baseline or upper G Subscript i Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0073.png"/></annotation-xml></semantics></math></span> with which the receptor is coupled, and the set of PKA target enzymes in the cell. By summing the influences that tend to increase and decrease [cAMP], a cell achieves the integration of signals that is a general feature of signal-transducing mechanisms (<a class="crossref" href="nel_9781319228002_ch12_02.xhtml#dav_9781319322342_0x0qnYVoNr" id="dav_9781319322342_VNVM2M1FbI">Fig. 12-1f</a>).</p>
<p class="indent" id="dav_9781319322342_Pz8weBmmcL">Another factor that explains how so many types of signals can be mediated by a single second messenger (cAMP) is the confinement of the signaling process to a specific region of the cell by <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_s14oSogSD2"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_XwjAxRr4c8" id="dav_9781319322342_RhV5F5npcW" role="doc-glossref">adaptor proteins</a></dfn> — noncatalytic proteins that hold together other protein molecules that function in concert (further described below). <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_g0AdvYlhav" role="presentation" src="../images/nelsonlehnpob8e_PG02.png"/><dfn class="keyword" epub:type="keyword" id="dav_9781319322342_YUEaeui6ud"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_snHdVpoLai" id="dav_9781319322342_5ICIr7eDqI" role="doc-glossref"> AKAPs (A kinase anchoring proteins)</a></dfn> have multiple, distinct protein-binding domains, often intrinsically disordered regions; they are multivalent adaptor proteins. One domain binds to the R subunits of PKA and another binds to a specific structure in the cell, confining the PKA to the vicinity of that structure. For example, specific AKAPs bind PKA to microtubules, actin filaments, ion channels, mitochondria, or the nucleus. Different types of cells have different complements of AKAPs, so cAMP might stimulate phosphorylation of mitochondrial proteins in one cell and stimulate phosphorylation of actin filaments in another. In some cases, an AKAP connects PKA with the enzyme that triggers PKA activation (adenylyl cyclase) or terminates PKA action (cAMP phosphodiesterase or phosphoprotein phosphatase) (<strong class="important" id="dav_9781319322342_OxKQ420rtt"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_nRuyq7XrmX" id="dav_9781319322342_DziHEwdlrL">Fig. 12-11</a></strong>). The very close proximity of these activating and inactivating enzymes presumably achieves a highly localized, and very brief, response.</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_nRuyq7XrmX">
<img alt="A figure shows how A kinase anchoring proteins can act as scaffolds for nucleation of supramolecular complexes." aria-describedby="dav_9781319322342_oxMgPo258m" class="figure" id="dav_9781319322342_kiq1h0KnFL" src="../images/nelsonlehnpob8e_12_11_301715.png"/>
<figcaption id="dav_9781319322342_3rcAa60vEu">
<p class="noindent" id="dav_9781319322342_utLfVxCMZw"><span class="label" epub:type="label" id="dav_9781319322342_E8E5JVIR0d">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_mpffhveuXU">12-11 </span><span class="title" id="dav_9781319322342_H2nr2r6LFj">Nucleation of supramolecular complexes by A kinase anchoring proteins (AKAPs).</span> AKAP5 is one of a family of proteins that act as multivalent scaffolds, holding PKA catalytic subunits — through interaction of the AKAP with the PKA regulatory subunits — in proximity to a particular region or structure in the cell. AKAP5 is targeted to rafts in the cytoplasmic face of the plasma membrane by two covalently attached palmitoyl groups and a site that binds phosphatidylinositol 3,4,5-trisphosphate <span class="math" id="dav_9781319322342_YxXJHvmHrO" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msub><mrow><mtext>PIP</mtext></mrow><mn>3</mn></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis PIP Subscript 3 Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0074.png"/></annotation-xml></semantics></math></span> in the membrane. AKAP5 also has binding sites for the <i class="semantic-i" id="dav_9781319322342_YI50IEN5y0">β</i>-adrenergic receptor, adenylyl cyclase, PKA, and a phosphoprotein phosphatase (PP2A), bringing them all together in the plane of the membrane. When epinephrine binds to the <i class="semantic-i" id="dav_9781319322342_THoFoclNCS">β</i>-adrenergic receptor, adenylyl cyclase produces cAMP, which reaches the nearby PKA quickly and with very little dilution. PKA phosphorylates its target protein, altering its activity, until the phosphoprotein phosphatase removes the phosphoryl group and returns the target protein to its prestimulus state. The AKAPs in this and other cases bring about a high local concentration of enzymes and second messengers, so that the signaling circuit remains highly localized and the duration of the signal is limited.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_oxMgPo258m" title="hidden">
<p class="noindent" id="dav_9781319322342_I7DIwzwWjY">A horizontal piece of membrane has a light red vertical rectangle labeled Greek letter beta-adrenergic receptor extending through its left side. This rectangle contains a thread that begins at its upper left and moves up and down. A hexagon with a protrusion on its left side is at the upper left of the rectangle. A large green oval extends almost horizontally under the left side of the light red rectangle and has a thread extending into the membrane from its upper left side, where it contacts a crescent-shaped green piece that has a thread extending into the membrane from its upper right and curves around an oval labeled G subscript s between it and the larger, almost horizontal oval to its right. On the right side of the membrane, there is a rectangle with its top half divided vertically in half labeled adenylyl cyclase. Between the Greek letter beta-adrenergic receptor and adenylyl cyclase, there is a long horizontal molecule labeled A K A P 5 that runs beneath the membrane with two threads extending into the membrane on its left side. On its right side, it has two protrusions between two membrane phosphate heads with a red sphere between them that has two red tails extending into the membrane that is labeled P I P subscript 3. Two threads labeled P K A cross in a cutout in the lower right side of A K A P 5. The left side runs horizontally and slightly up to the left against a cutout in A K A P 5, then bends vertically down to run through a groove in a blue sphere labeled C to end in a light red sphere labeled R. The right side runs horizontally and slightly up to the right against a cutout in A K A P 5, then bends vertically down to run through a groove in a blue sphere labeled C to end in a light red sphere labeled R. In a blunt triangular cutout in the lower left of A K A P 5, there is a blue protein labeled P P 2 A with an oval bottom with a blunt triangular protrusion. A light blue oval beneath P P 2 A has a green circle labeled P attached to its right side and a curved arrow above that runs against P P 2 A before splitting to show the loss of P subscript 1 and production of a light blue oval labeled target protein. A second curved arrow extends down from the target protein and is joined by A T P to produce the original light blue oval. A T P has a curved arrow through the lower right of adenylyl cyclase to produce c A M P, from which a dashed arrow points to the red thread of P K A. An arrow points down from the adjacent sphere labeled C to beneath the light blue oval bound to a green circle labeled P, where there is a similar blue sphere with short lines radiating from all sides.</p>
</aside>
<p class="indent" id="dav_9781319322342_dBMf0QJSU4">In a process analogous with the cAMP-PKA pathway, a cyclic derivative of GTP (<span class="math" id="dav_9781319322342_J9E900wpLT" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="3 prime" src="../images/MATH/nel_9781319228002_ch12_03EQ_0075.png"/></annotation-xml></semantics></math></span>,<span class="math" id="dav_9781319322342_ciwMRlEfJp" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mn>5</mn><mo>′</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="5 prime" src="../images/MATH/nel_9781319228002_ch12_03EQ_0076.png"/></annotation-xml></semantics></math></span>-cyclic GMP; cGMP) is generated in response to an extracellular signal. The cGMP activates a cGMP-dependent protein kinase (PKG), which phosphorylates specific protein substrates, changing their activities in response to the initial signal (<strong class="important" id="dav_9781319322342_fY4eenk6Py"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_CHLZlvEAXe" id="dav_9781319322342_fKLDc934i5">Box 12-2</a></strong>).</p>
<aside class="case-study c3 main-flow v3" epub:type="case-study" id="dav_9781319322342_CHLZlvEAXe" title="Box 12-2 Medicine">
<header id="dav_9781319322342_M4I4plFZuc"><h5 class="title v3 cap" epub:type="title" id="dav_9781319322342_gZaMe26t9i">Box 12-2 <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_S9wdm7NEtj" role="presentation" src="../images/nelsonlehnpob8e_02_un01_PG056eps.png"/> MEDICINE</h5>
<p class="subtitle" epub:type="subtitle" id="dav_9781319322342_jkJamLBgOr" role="doc-subtitle">Receptor Guanylyl Cyclases, cGMP, and Protein Kinase G</p></header>
<p class="noindent" id="dav_9781319322342_4DaFpd7ylS">Guanylyl cyclases (<strong class="important" id="dav_9781319322342_YL0fVc75iR"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_haevl2hzjl" id="dav_9781319322342_7B5KtwQz03">Fig. 1</a></strong>) are receptor enzymes that, when activated, convert GTP to the second messenger <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_1peiNPzroJ">guanosine <span class="math" id="dav_9781319322342_APSaU7T4OJ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="3 prime" src="../images/MATH/nel_9781319228002_ch12_03EQ_0077.png"/></annotation-xml></semantics></math></span>,<span class="math" id="dav_9781319322342_d6ywT37ZMs" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mn>5</mn><mo>′</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="5 prime" src="../images/MATH/nel_9781319228002_ch12_03EQ_0078.png"/></annotation-xml></semantics></math></span>-cyclic monophosphate (cGMP)</dfn> (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_haevl2hzjl" id="dav_9781319322342_X77Sr86i1G">Fig. 2</a>). Many of the actions of cGMP in animals are mediated by <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_cgg8QSivqV">cGMP-dependent protein kinase, also called protein kinase G (PKG)</dfn>. On activation by cGMP, PKG phosphorylates Ser and Thr residues in target proteins. The catalytic and regulatory domains of this enzyme are in a single polypeptide (<span class="math" id="dav_9781319322342_dllQpvrhYk" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>M</mi><mtext>r</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r" src="../images/MATH/nel_9781319228002_ch12_03EQ_0079.png"/></annotation-xml></semantics></math></span> ~80,000). Part of the regulatory domain fits snugly in the substrate-binding cleft. Binding of cGMP forces this activation loop out of the binding site, opening the site to PKG target proteins.</p>
<figure class="figure lm_img_lightbox num c5 center" id="dav_9781319322342_haevl2hzjl">
<img alt="A figure shows the structures of two types of signal-transducing guanylyl cyclase with part a showing an A N F receptor and an example of a guanylin and endotoxin receptor as examples of membrane-spanning guanylyl cyclases and part b showing a soluble N O-activated guanylyl cyclase." aria-describedby="dav_9781319322342_g06nELQWi5" class="figure" id="dav_9781319322342_BaDH7xpZfA" src="../images/nelsonlehnpob8e_12_box0201_301753.png"/>
<figcaption id="dav_9781319322342_kc9qPbmQ3w">
<p class="noindent" id="dav_9781319322342_hpUgZBBkmo"><span class="label" epub:type="label" id="dav_9781319322342_biLEUCidjr">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_F1BXAEBogK">1 </span>Two types of signal-transducing guanylyl cyclase. (a) Membrane-spanning guanylyl cyclases such as the ANF and guanylin receptors are homodimers with an extracellular ligand-binding domain and an intracellular guanylyl cyclase domain. (b) A soluble heme-containing guanylyl cyclase is activated by intracellular NO.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_g06nELQWi5" title="hidden">
<p class="noindent" id="dav_9781319322342_wFdrZB055N">A horizontal piece of membrane shows the extracellular ligand-binding (receptor) domains of two receptors above the membrane and the intracellular catalytic (c G M P-forming) domains below the membrane. Part a is labeled membrane-spanning guanylyl cyclases. The left-hand structure is labeled A N F receptor. It has two light red rectangles above the membrane that each bend slightly toward the center, so they meet on top and are separate at the bottom. A green diamond labeled A N F is between them just below the midpoint of the structure. Each has a blue vertical line that extends down across the membrane. These blue lines each form a sphere beneath the membrane with short lines radiating from all sides. G T P is shown with a curved line running through the bottom of the right-hand blue circle to c G M P. The right-hand molecule is labeled guanylin and endotoxin receptors. It has a similar structure, except that the two light red halves each have cutouts to form a diamond-shaped opening just below the midpoint labeled ligand-binding site. Part b is labeled soluble N O-activated guanylyl cyclase. It shows a blue circle containing a light red diamond labeled F e inside the circle with its right side vertex joined to the right side of the circle. This light red diamond is labeled heme.</p>
</aside>
<figure class="figure lm_img_lightbox num c5 center" id="dav_9781319322342_sI7bqQnwgU">
<img alt="A figure shows how guanosine 5 prime-monophosphate (G M P) is formed from G T P in two steps." aria-describedby="dav_9781319322342_2dxig4uaU9" class="figure" id="dav_9781319322342_ANEcHKMYAI" src="../images/nelsonlehnpob8e_12_box0202_301754.png"/>
<figcaption id="dav_9781319322342_mWvNvznJyy">
<p class="noindent" id="dav_9781319322342_d6S3R7svwn"><span class="label" epub:type="label" id="dav_9781319322342_YTgX4jBAkO">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_pC5X06NUfr">2 </span>Synthesis of cGMP by guanylyl cyclase and its hydrolysis by cGMP phosphodiesterase.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_2dxig4uaU9" title="hidden">
<p class="noindent" id="dav_9781319322342_SQ1Mk2g7iM">G T P has a five-membered ring with O substituted for C at position 6 at the top vertex, C 1 prime bonded to N of the lower right vertex of a five-membered ring above and to H below, C 2 prime and C 3 prime bonded to H above and O H below, C 4 prime bonded to C 5 prime above and to H below, and C 5 prime bonded to 2 H and to O bonded to P double bonded to O above, bonded to O minus below, and bonded to P to the left double bonded to O above, bonded to O minus below, and bonded to P on the left double bonded to O above, bonded to O minus below, and bonded to O minus to the left. The five-membered ring shares its left side with a six-membered ring. It has N substituted for C at its upper right vertex at position 7, a double bond at its upper right side between positions 7 and 8, a double bond at its left side between positions 4 and 5, and N substituted for C at its lower right vertex at position 9 and further bonded to C 1 prime of the ring below. The six-membered ring has double bond at its right side between positions 4 and 5 shared with the five-membered ring, a double bond at its lower left side between positions 2 and 3, N substituted for C at its upper left vertex at position 1 and bonded to H, N substituted for C at its bottom vertex at position 3, its lower left vertex at position 2 bonded to N H 2, and its top vertex, C 6, double bonded to O. An arrow pointing right is labeled guanylyl cyclase and has an arrow from it showing that P P subscript 1 leaves. This yields guanosine 3 prime, 5 prime-cyclic monophosphate (c G M P). It has a similar structure to G T P except that C 3 prime is bonded to H above and to O below that is bonded to P to the left that is bonded to O minus below, double bonded to O to the left, and bonded to O above that is bonded to C 5 prime on the right that is bonded to 2 H and to C 4 prime of the ring below. An arrow pointing right is labeled cyclic nucleotide phosphodiesterase and is joined by an arrow representing the addition of H 2 O. This yields guanosine 5 prime-monophosphate. It has a similar structure except that C 3 prime is bonded to H above and O H below and C 5 prime is bonded to 2 H and to O bonded to P double bonded to O above and bonded to O minus below and to the left.</p>
</aside>
<p class="indent" id="dav_9781319322342_ynZjIbAvCk">Cyclic GMP carries different messages in different tissues. In cardiac muscle (a type of smooth muscle), it signals relaxation. In the kidney and the intestine, it triggers changes in ion transport and water retention. Guanylyl cyclase in the kidney is activated by the peptide hormone <strong class="important" id="dav_9781319322342_U8PFUkWygA">atrial natriuretic factor (ANF</strong>; <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_haevl2hzjl" id="dav_9781319322342_o0gKw8aSdy">Fig. 1a</a>), which is released by cells in the cardiac atrium when the heart is stretched by increased blood volume. Carried in the blood to the kidney, ANF activates guanylyl cyclase in cells of the collecting ducts. The resulting rise in [cGMP] triggers increased renal excretion of <span class="math" id="dav_9781319322342_qfb3sfON9F" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Na</mtext></mrow><mo>+</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Na Superscript plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0080.png"/></annotation-xml></semantics></math></span> and consequently of water, driven by the change in osmotic pressure. Water loss reduces the blood volume, countering the stimulus that initially led to ANF secretion. Vascular smooth muscle also has an ANF receptor–guanylyl cyclase; on binding to this receptor, ANF causes relaxation (vasodilation) of the blood vessels, which increases blood flow while decreasing blood pressure.</p>
<p class="indent" id="dav_9781319322342_3z89OjBWrz">A similar receptor guanylyl cyclase in the plasma membrane of epithelial cells lining the intestine is activated by the peptide <strong class="important" id="dav_9781319322342_GiriX7HPna">guanylin</strong> (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_haevl2hzjl" id="dav_9781319322342_AiRDufxlMf">Fig. 1a</a>), which regulates <span class="math" id="dav_9781319322342_6IYb6prGvM" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Cl</mtext></mrow><mo>−</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Cl Superscript minus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0081.png"/></annotation-xml></semantics></math></span> secretion in the intestine. This receptor is also the target of a heat-stable peptide endotoxin produced by <i class="semantic-i" id="dav_9781319322342_7O0dsIosGV">Escherichia coli</i> and other gram-negative bacteria. The elevation in [cGMP] caused by the endotoxin increases <span class="math" id="dav_9781319322342_8z0zElh4f9" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>CI</mtext></mrow><mo>−</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="CI Superscript minus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0082.png"/></annotation-xml></semantics></math></span> secretion and consequently decreases reabsorption of water by the intestinal epithelium, producing diarrhea.</p>
<p class="indent" id="dav_9781319322342_mPJM2yTPM8">A distinctly different type of guanylyl cyclase is a soluble cytosolic protein with a tightly associated heme group (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_sI7bqQnwgU" id="dav_9781319322342_fBTbCmReLl">Fig. 1b</a>), an enzyme activated by nitric oxide (NO). Nitric oxide is produced from arginine by <span class="math" id="dav_9781319322342_rEfrG7hZ6l" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0083.png"/></annotation-xml></semantics></math></span>-dependent <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_HX0WZSENKt">NO synthase</dfn>, present in many mammalian tissues, and diffuses from its cell of origin into nearby cells (see <a class="crossref" href="nel_9781319228002_ch22_01.xhtml#dav_9781319322342_3FcCzyZlhu" id="dav_9781319322342_p8g7f7fowR">Chapter 22</a>).</p>
<p class="indent" id="dav_9781319322342_3DSthi9SFv">In the target cell, NO binds to the heme group of guanylyl cyclase and activates cGMP production. In the heart, cGMP-dependent protein kinase reduces the forcefulness of contractions by stimulating the ion pump(s) that remove <span class="math" id="dav_9781319322342_Qti00SawLj" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0084.png"/></annotation-xml></semantics></math></span> from the cytosol. NO-induced relaxation of cardiac muscle is the same response brought about by nitroglycerin and other nitrovasodilators taken to relieve <strong class="important" id="dav_9781319322342_iD3RwSXIM9">angina pectoris</strong>, the pain caused by contraction of a heart deprived of <span class="math" id="dav_9781319322342_rt2PRDE6eh" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>O</mtext><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper O Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0085.png"/></annotation-xml></semantics></math></span> because of blocked coronary arteries. Nitric oxide is unstable and its action is brief; within seconds of its formation, it undergoes oxidation to nitrite or nitrate. Nitrovasodilator drugs produce long-lasting relaxation of cardiac muscle because they break down over several hours, yielding a steady stream of NO. The value of nitroglycerin as a treatment for angina was discovered serendipitously in factories producing nitroglycerin as an explosive in the 1860s. Workers with angina reported that their condition was much improved during the workweek but worsened on weekends. The physicians treating these workers heard this story so often that they made the connection, and a drug was born.</p>
<p class="indent" id="dav_9781319322342_jlIPdvqPGW">The effects of increased cGMP synthesis diminish after the stimulus ceases, because a specific phosphodiesterase (cGMP PDE) converts cGMP to the inactive <span class="math" id="dav_9781319322342_wicM8ZaBwZ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mn>5</mn><mo>′</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="5 prime" src="../images/MATH/nel_9781319228002_ch12_03EQ_0086.png"/></annotation-xml></semantics></math></span>-GMP (see <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_sI7bqQnwgU" id="dav_9781319322342_U1G6DW03JW">Fig. 2</a>). Humans have several isoforms of cGMP PDE, with different tissue distributions. The isoform in the blood vessels of the penis is inhibited by the drugs sildenafil (Viagra) and tadalafil (Cialis), which therefore cause [cGMP] to remain elevated once raised by an appropriate stimulus, accounting for the usefulness of this drug in the treatment of erectile dysfunction.</p>
<figure class="figure lm_img_lightbox unnum c3 center" id="dav_9781319322342_ODS4AxvNeB">
<img alt="A figure shows the structures of sildenafil (Viagra) and tadalafil (Cialis)." aria-describedby="dav_9781319322342_3DaPWSebMQ" class="figure" id="dav_9781319322342_2HBpcIQQgs" src="../images/nelsonlehnpob8e_12_box02un01-02_301755.png"/>
</figure>
<aside class="hidden" id="dav_9781319322342_3DaPWSebMQ" title="hidden">
<p class="noindent" id="dav_9781319322342_4WGjIs0HLb">Sildenafil (Viagra) has a benzene ring with three substituents: the upper left vertex is bonded to S double bonded to O to the upper left and upper right and bonded to N to its lower left that is substituted for C at the top right vertex of a six-membered ring with another N substituted for C at its lower left vertex and bonded to C H 3; the lower right vertex is bonded to O further bonded to a two-carbon chain; and the upper right vertex is bonded to the lower left vertex of a six-membered ring that shares its right side with a five-membered ring. The six-membered ring has N substituted for C at its bottom vertex, N substituted for C at its upper left vertex and bonded to H, double bonds at its lower left side and right side, and its top vertex double bonded to O. The five-membered ring has a double bond on its left side shared with the six-membered ring, a double bond at its lower right side, N substituted for C at its upper right vertex and bonded to C H 3, N substituted for C at its right side vertex, and its lower right vertex bonded to a three-carbon chain. Tadalafil (Cialis) has a benzene ring that shares the double bond at its lower right side with a five-membered ring that has O at its right side and lower left vertices and C H 2 at its lower right vertex. The top vertex of the benzene ring is bonded to the bottom vertex of a six-membered ring above that shares its right side with a six-membered ring and a double bond on its left side with a five-membered ring and that has N substituted for C at its lower right vertex shared with the right-hand six-membered ring. The right-hand six-membered ring also has N substituted for C at its upper right vertex and bonded to C H 3 and its top and bottom vertices both double bonded to O. The five-membered ring on the left has N substituted for C at its bottom vertex and bonded to H and its upper left side shared with a benzene ring.</p>
</aside>
</aside>
</section>
<section class="sect2" id="dav_9781319322342_3WWvwMZRtu">
<header id="dav_9781319322342_GKmQtL3DIi"><h4 class="b-head v3" id="dav_9781319322342_SUBX6FARhj">G Proteins Act as Self-Limiting Switches in Many Processes</h4></header>
<p class="noindent" id="dav_9781319322342_iIEEYGgeSJ">Proteins sensitive to the binding of either GTP or GDP play critical roles in many cellular processes, including sensory perception, signaling for cell division, growth <span aria-label="421" epub:type="pagebreak" id="page421" role="doc-pagebreak"/>and differentiation, intracellular movements of proteins and membrane vesicles, and protein synthesis. The human genome encodes nearly 200 of these proteins, which differ in size and subunit structure, intracellular location, and function. But all G proteins share a common feature: they can become activated by binding GTP and then, after a brief period, can inactivate themselves with their GTPase activity, thereby serving as molecular binary switches with built-in timers. This superfamily of proteins includes the trimeric G proteins involved in <i class="semantic-i" id="dav_9781319322342_sXhRKU9pqx">β</i>-adrenergic signaling (<span class="math" id="dav_9781319322342_YXz3TJVzYq" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0087.png"/></annotation-xml></semantics></math></span> or <span class="math" id="dav_9781319322342_MHaJMxGism" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>i</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript i" src="../images/MATH/nel_9781319228002_ch12_03EQ_0088.png"/></annotation-xml></semantics></math></span>) and vision (transducin); small, monomeric G proteins such as that involved in insulin signaling (Ras; see below) and others that function in vesicle trafficking (ARF, RAC1, and Rab), transport into and out of the nucleus (Ran), and timing of the cell cycle (Rho); and several proteins involved in protein synthesis (initiation factor IF2 and elongation factors EF-Tu and EF-G; see <a class="crossref" href="nel_9781319228002_ch27_01.xhtml#dav_9781319322342_YpAiA5I1wG" id="dav_9781319322342_4okyqucjMM">Chapter 27</a>). Among the trimeric G proteins, <span class="math" id="dav_9781319322342_6K1kUUIblO" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mi>α</mi></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0089.png"/></annotation-xml></semantics></math></span> subunits have covalently linked lipids: the amino terminus is palmitoylated, and some are also myristoylated. <span class="math" id="dav_9781319322342_khQ1xkn8FN" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mi>γ</mi></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript gamma" src="../images/MATH/nel_9781319228002_ch12_03EQ_0090.png"/></annotation-xml></semantics></math></span> and the monomeric Ras protein have an isoprenyl lipid at their carboxyl termini. The attached lipids keep them anchored to the plasma membrane, restricting their action to that two-dimensional plane.</p>
<p class="indent" id="dav_9781319322342_NrxD2acBcY">All G proteins have the same core structure and use the same mechanism for switching between an inactive conformation, favored when GDP is bound, and an active conformation, favored when GTP is bound. We can use <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_7cmLUBgpor"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_TRnkiCBjWa" id="dav_9781319322342_o4xeBn8SAG" role="doc-glossref">Ras</a></dfn> (~20 kDa, a minimal signaling unit) as a prototype for all members of this superfamily (<strong class="important" id="dav_9781319322342_HEdzzeNXRk"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_DxjOZitSCe" id="dav_9781319322342_iHyWhIuFHw">Fig. 12-12</a></strong>).</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_DxjOZitSCe">
<img alt="The ribbon structure of the G-protein phenotype of R a s is shown, including switch Roman numeral I, switch Roman numeral 2, and a P loop. M g 2 plus is shown and there is a G T P analog in the G T P-binding site. The critical residues involved in binding labeled." aria-describedby="dav_9781319322342_z0BMY3NVs2" class="figure" id="dav_9781319322342_BUA6R3ynMf" src="../images/nelsonlehnpob8e_12_12_301716.png"/>
<figcaption id="dav_9781319322342_nT8DJg6axt">
<p class="noindent" id="dav_9781319322342_s2LECJUZ9Q"><span class="label" epub:type="label" id="dav_9781319322342_kuVdjXG1EN">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_KHt1JkZfEi">12-12 </span><span class="title" id="dav_9781319322342_MTVIm9Jw4I">Ras, the G-protein prototype. </span><span class="math" id="dav_9781319322342_I8NvusyuUl" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Mg</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Mg Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0091.png"/></annotation-xml></semantics></math></span>-GTP is held by critical residues in the phosphate-binding P loop (blue) and by <span class="math" id="dav_9781319322342_aE6jjk9jvS" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Thr</mtext></mrow><mrow><mn>35</mn></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Thr Superscript 35" src="../images/MATH/nel_9781319228002_ch12_03EQ_0092.png"/></annotation-xml></semantics></math></span> in the switch I region (red) and <span class="math" id="dav_9781319322342_jfUrD18MqK" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Gly</mtext></mrow><mrow><mn>60</mn></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Gly Superscript 60" src="../images/MATH/nel_9781319228002_ch12_03EQ_0093.png"/></annotation-xml></semantics></math></span> in the switch II region (green). <span class="math" id="dav_9781319322342_OJxwFbux6Q" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ala</mtext></mrow><mrow><mn>146</mn></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ala Superscript 146" src="../images/MATH/nel_9781319228002_ch12_03EQ_0094.png"/></annotation-xml></semantics></math></span> gives specificity for GTP over ATP. In the structure shown here, the nonhydrolyzable GTP analog Gpp(NH)p is in the GTP-binding site. [Data from PDB ID 5P21, E. F. Pai et al., <i class="semantic-i" id="dav_9781319322342_m4UTHImcZB">EMBO J.</i> 9:2351, 1990.]</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_z0BMY3NVs2" title="hidden">
<p class="noindent" id="dav_9781319322342_TlEK70G9eH">The ribbon structure shows a ball-and-stick model on the left side with highlighted strands around it that interact with a G T P analog and with M g 2 plus. The ribbon structure has a short white helix at the lower left that extends diagonally up to the right to a top coil that is purple and that contacts a green sphere labeled M g 2 plus at its upper right end. Another white helix extends diagonally down to the lower right behind it, running behind three beta strands. At the right side, a green thread leads to a short green helix that runs up and slightly to the right, where it overlaps with a piece near the bottom of a long white helix that runs up toward the left to end near the top center of the protein. The long white helix has a short helix that runs parallel and slightly behind it near its top. The green helix is labeled switch Roman numeral 2 and has a strand extending rom its top left into the center, where it becomes purple as it crosses a vertical purple strand behind and then bends down to the left with a purple region labeled G l y superscript 60 before becoming green again continuing down to meet the beta strands below. To the left of the strand with the G l y superscript 60, there are two beta strands running almost vertically up to the center and slightly to the left. Farther to the left, beneath the top ends of these two beta strands, there is a ball-and stick model labeled G T P analog that runs up and to the left with the green sphere labeled M g plus below its lower right. A wavy red strand runs across the M g 2 plus and curves down to meet one of the three beta strands at the bottom center to its lower right and bends upward to run along the lower half of the G T P analog before bending down to run almost vertically along the left side, where it is labeled switch Roman numeral 1. A white strand loops behind the red strand labeled switch Roman numeral 1 and has a yellow region labeled A l a superscript 1 46 that is beneath the G T P analog and about halfway between the left and right halves of the red strand that loops up along the G T P analog above. Where the red strand runs across M g 2 plus, there are two red sticks. The upper red stick runs along the bottom of the M g 2 plus and the lower one runs down and to the right and is labeled T h r superscript 35. The G T P analog has a chain of three phosphates running above M g 2 plus and a carbon chain on the left side.</p>
</aside>
<p class="indent" id="dav_9781319322342_qbMe5PUBjv">In the nucleotide-binding site of Ras, <span class="math" id="dav_9781319322342_fwmpKnIl8b" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ala</mtext></mrow><mrow><mn>146</mn></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ala Superscript 146" src="../images/MATH/nel_9781319228002_ch12_03EQ_0095.png"/></annotation-xml></semantics></math></span> hydrogen bonds to the guanine oxygen, allowing GTP, but not ATP, to bind. In the GTP-bound conformation, the G protein exposes previously buried regions (called <strong class="important" id="dav_9781319322342_X8FEwA0Klg">switch I</strong> and <strong class="important" id="dav_9781319322342_BMySKXNWgI">switch II</strong>) that interact with proteins downstream in the signaling pathway until the G protein inactivates itself by hydrolyzing its bound GTP to GDP. The critical determinant of G-protein conformation is the <i class="semantic-i" id="dav_9781319322342_JMbwnXzOzj">γ</i> phosphate of GTP, which interacts with a region called the <strong class="important" id="dav_9781319322342_SVBCkR6Ih5">P loop</strong> (<i class="semantic-i" id="dav_9781319322342_oJPCt2x3fm">p</i>hosphate-binding). In Ras, the <i class="semantic-i" id="dav_9781319322342_alFZ2LxIQ9">γ</i> phosphate of GTP binds to a Lys residue in the P loop and to two critical residues, <span class="math" id="dav_9781319322342_BMKBYgLw8s" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Thr</mtext></mrow><mrow><mn>35</mn></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Thr Superscript 35" src="../images/MATH/nel_9781319228002_ch12_03EQ_0096.png"/></annotation-xml></semantics></math></span> in switch I and <span class="math" id="dav_9781319322342_rFfLTzw8DV" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Gly</mtext></mrow><mrow><mn>60</mn></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Gly Superscript 60" src="../images/MATH/nel_9781319228002_ch12_03EQ_0097.png"/></annotation-xml></semantics></math></span> in switch II, that hydrogen-bond with the oxygens of the <i class="semantic-i" id="dav_9781319322342_Z59NJ6Qb99">γ</i> phosphate of GTP. These hydrogen bonds act like a pair of springs holding the protein in its active <span aria-label="422" epub:type="pagebreak" id="page422" role="doc-pagebreak"/>conformation (<strong class="important" id="dav_9781319322342_UYsH3czOeN"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_0aWz83N7hg" id="dav_9781319322342_QBvmv4GtG3">Fig. 12-13</a></strong>). When GTP is cleaved to GDP, and <span class="math" id="dav_9781319322342_OYFuK5cxsr" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>P</mtext><mtext>i</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper P Subscript i" src="../images/MATH/nel_9781319228002_ch12_03EQ_0098.png"/></annotation-xml></semantics></math></span> is released, these hydrogen bonds are lost; the protein then relaxes into its inactive conformation, burying switch I and II so they are no longer available to interact with other partners.</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_0aWz83N7hg">
<img alt="A figure shows how G T P hydrolysis affects the structure of R a s, flipping its switches." aria-describedby="dav_9781319322342_JVL0CSPpo9" class="figure" id="dav_9781319322342_ziuqFX9nRf" src="../images/nelsonlehnpob8e_12_13_301717.png"/>
<figcaption id="dav_9781319322342_0W5FUwSxxy">
<p class="noindent" id="dav_9781319322342_ACVmmgewN2"><span class="label" epub:type="label" id="dav_9781319322342_R8MZ453Ppm">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_wpfN1EERec">12-13 </span><span class="title" id="dav_9781319322342_KQ9jgxWIDY">GTP hydrolysis flips the switches in Ras.</span> When bound GTP is hydrolyzed by the GTPase activities of Ras and its GTPase activator protein (GAP), loss of hydrogen bonds to <span class="math" id="dav_9781319322342_jd9pYrKGbo" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Thr</mtext></mrow><mrow><mn>35</mn></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Thr Superscript 35" src="../images/MATH/nel_9781319228002_ch12_03EQ_0099.png"/></annotation-xml></semantics></math></span> and <span class="math" id="dav_9781319322342_2DHLBKXIVi" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Gly</mtext></mrow><mrow><mn>60</mn></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Gly Superscript 60" src="../images/MATH/nel_9781319228002_ch12_03EQ_0100.png"/></annotation-xml></semantics></math></span> allows the switch I and switch II regions to relax into a conformation in which they are no longer available to interact with downstream targets. [Information from I. R. Vetter and A. Wittinghofer, <i class="semantic-i" id="dav_9781319322342_bXRbSBz3i7">Science</i> 294:1299, 2001, Fig. 3.]</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_JVL0CSPpo9" title="hidden">
<p class="noindent" id="dav_9781319322342_uyfqKGIXh6">A blunt pyramidal structure in blue is labeled P loop at its peak, which contains a phosphate group of G T P. The pyramidal structure has crescent-shaped pieces that curve up to the left and right. The pyramid is gray at the bottom and increasingly blue toward the top. The left-hand piece, labeled switch Roman numeral 1, curves to the left, where it is gray, and then curves back to the right as it becomes increasingly light red. It ends at T h r superscript 35 with a helix extending right to O minus of the top P of G T P in the peak of the pyramid. The right-hand piece, labeled switch Roman numeral 2, curves to the right, where it is gray, and then curves back to the left as it becomes increasingly green. It ends at G l y superscript 60 with a helix extending left to the right-hand O minus of the top P of G T P in the peak of the pyramid. A rectangle labeled guanosine in the gray region at the bottom center of the structure has three phosphates in a vertical chain above it. It is bonded to O bonded to P double bonded to O on the right, bonded to O minus on the left, and bonded to P above double bonded to O on the right, bonded to O minus on the left, and bonded to O above that is bonded to the final P by a bond with scissors across it. This P is double bonded to O on the left connected by a helix to T h r superscript 35 in the left-hand piece and to O on the right connected by a helix to G l y superscript 60 in the right-hand piece. The top of the left-hand and right hand pieces each have an arrow pointing to a faded piece showing how they bend outward when the bond between O and P is cut in the center piece.</p>
</aside>
<p class="noindent" id="dav_9781319322342_9NmUmVVy7X">The GTPase activity of most G proteins is very weak, but it is increased up to <span class="math" id="dav_9781319322342_sgXEfGsgIj" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mn>10</mn></mrow><mn>5</mn></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="10 Superscript 5" src="../images/MATH/nel_9781319228002_ch12_03EQ_0101.png"/></annotation-xml></semantics></math></span>-fold by <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_u7Tmodi11L"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_3dvGo49Shh" id="dav_9781319322342_sblMxv9reh" role="doc-glossref">GTPase activator proteins (GAPs)</a></dfn>, also called, in the case of heterotrimeric G proteins, <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_wRR1gNabKD"><a class="glossref" epub:type="glossref" href="nel_9781319228002_EM_glossary.xhtml#dav_9781319322342_fTyLAbWOci" id="dav_9781319322342_O1OybBuA6J" role="doc-glossref">regulators of G-protein signaling (RGSs</a></dfn>; <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_pzaM52Svls" id="dav_9781319322342_du7V4RvLGk">Fig. 12-8</a>). GAPs and RGSs thus determine how long the G-protein switch remains on. There are about 40 different RGS proteins associated with a variety of processes and expressed in most tissues. They have a critical Arg residue that reaches into the G-protein GTPase active site and contributes to catalysis. The intrinsically slow process of replacing bound GDP with GTP, switching the protein on, is catalyzed by <strong class="important" id="dav_9781319322342_7AC1mcPrFb">guanosine nucleotide–exchange factors (GEFs</strong>, such as the <i class="semantic-i" id="dav_9781319322342_DHQXx1Wnav">β</i>-adrenergic receptor) associated with the G protein. The ligand-bound <i class="semantic-i" id="dav_9781319322342_A8U5DCkwxZ">β</i>-adrenergic receptor is one of many GEFs, and a broad <span aria-label="423" epub:type="pagebreak" id="page423" role="doc-pagebreak"/>range of proteins act as GAPs. Their combined effects set the level of GTP-bound G proteins, and thus the strength of the response to signals that arrive at the receptors.</p>
<p class="noindent" id="dav_9781319322342_RY406NYnLz"><img alt="" aria-hidden="true" class="decorative size-large inline" id="dav_9781319322342_lCvuF6dJYD" role="presentation" src="../images/nelsonlehnpob8e_IC_pg_37.png"/><span class="keep" id="dav_9781319322342_uHbLjyg7Yk"> </span><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_sTufTecqqk" role="presentation" src="../images/nelsonlehnpob8e_12_PG230f.png"/> Because G proteins play crucial roles in so many signaling processes, it is not surprising that defects in G proteins lead to a variety of diseases. In about 25% of all human cancers (and in a much higher proportion of certain types of cancer), a mutation in a Ras protein — typically in one of the critical residues around the GTP-binding site or in the P loop — virtually eliminates its GTPase activity. Once activated by GTP binding, this Ras protein remains constantly active, promoting cell division in cells that should not divide. The tumor suppressor gene <i class="semantic-i" id="dav_9781319322342_C9bbJyd0Z7">NF1</i> encodes a GAP that enhances the GTPase activity of normal Ras. Mutations in <i class="semantic-i" id="dav_9781319322342_Ya8u5KmSg8">NF1</i> that result in a nonfunctioning GAP leave Ras with only its GTPase activity, which is very weak (that is, has a very low turnover number); once activated by GTP binding, Ras stays active for an extended period, continuing to send the signal: divide.</p>
<p class="indent" id="dav_9781319322342_7rY1G1IPb0"><span aria-label="424" epub:type="pagebreak" id="page424" role="doc-pagebreak"/>Defective heterotrimeric G proteins can also lead to disease. Mutations in the gene that encodes the <i class="semantic-i" id="dav_9781319322342_tnTdAU5ABk">α</i> subunit of <span class="math" id="dav_9781319322342_VPIqVRlzKJ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0102.png"/></annotation-xml></semantics></math></span> (which mediates changes in [cAMP] in response to hormonal stimuli) may result in a <span class="math" id="dav_9781319322342_sUJSNLKK4h" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mi>α</mi></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0103.png"/></annotation-xml></semantics></math></span> that is permanently active or permanently inactive. “Activating” mutations generally occur in residues crucial to GTPase activity; they lead to a continuously elevated [cAMP], with significant downstream consequences, including undesirable cell proliferation. Such mutations are found in about 40% of pituitary tumors (adenomas). Individuals with “inactivating” mutations in <span class="math" id="dav_9781319322342_qXpydbRutK" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mi>α</mi></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0104.png"/></annotation-xml></semantics></math></span> are unresponsive to hormones (such as thyroid hormone) that act through cAMP. Mutation in the gene for the transducin <i class="semantic-i" id="dav_9781319322342_emRvMRj7Fo">α</i> subunit <span class="math" id="dav_9781319322342_gIF289dB0p" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mo stretchy="false">(</mo><mtext>T</mtext></mrow><mi>α</mi></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis upper T Subscript alpha Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0105.png"/></annotation-xml></semantics></math></span>, which is involved in visual signaling, leads to a type of night blindness, apparently due to defective interaction between the activated <span class="math" id="dav_9781319322342_JV5Tuy0JNk" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>T</mtext><mi>α</mi></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper T Subscript alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0106.png"/></annotation-xml></semantics></math></span> subunit and the phosphodiesterase of the rod outer segment (see <a class="crossref" href="nel_9781319228002_ch12_04.xhtml#dav_9781319322342_PcbdtZj7I6" id="dav_9781319322342_ArFz4FCNFv">Fig. 12-19</a>). A sequence variation in the gene encoding the <i class="semantic-i" id="dav_9781319322342_1cEfBhSXZE">β</i> subunit of a heterotrimeric G protein is commonly found in individuals with hypertension (high blood pressure), and this variant gene is suspected of involvement in obesity and atherosclerosis.</p>
<p class="indent" id="dav_9781319322342_xQ4EASQyBO">The pathogenic bacterium that causes cholera produces a toxin that targets a G protein, interfering with normal signaling in host cells. <strong class="important" id="dav_9781319322342_q9UVopCFx2">Cholera toxin</strong>, secreted by <i class="semantic-i" id="dav_9781319322342_6Zv4X7RqRM">Vibrio cholerae</i> in the intestine of an infected person, is a heterodimeric protein. Subunit B recognizes and binds to specific gangliosides on the surface of intestinal epithelial cells and provides a route for subunit A to enter these cells. After entry, subunit A is broken into two fragments, A1 and A2. A1 associates with the host cell’s ADP-ribosylation factor ARF6, a small G protein, through residues in its switch I and switch II regions — which are accessible only when ARF6 is in its active (GTP-bound) form. This association with ARF6 activates A1, which catalyzes the transfer of ADP-ribose from <span class="math" id="dav_9781319322342_fDjJmkXBzM" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>NAD</mtext></mrow><mo>+</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="NAD Superscript plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0107.png"/></annotation-xml></semantics></math></span> to the critical Arg residue in the P loop of the <i class="semantic-i" id="dav_9781319322342_pEMrEsSjrM">α</i> subunit of <span class="math" id="dav_9781319322342_fNZx78Uzg3" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0108.png"/></annotation-xml></semantics></math></span><strong class="important" id="dav_9781319322342_AZgo8nqL8E"> (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_Vy26tIoKQi" id="dav_9781319322342_2BFkd2MEZ5">Fig. 12-14</a></strong>). ADP-ribosylation <span aria-label="425" epub:type="pagebreak" id="page425" role="doc-pagebreak"/>blocks the GTPase activity of <span class="math" id="dav_9781319322342_O8zF72dmbO" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0109.png"/></annotation-xml></semantics></math></span> and thereby renders <span class="math" id="dav_9781319322342_ZXV5LZYXSR" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0110.png"/></annotation-xml></semantics></math></span> permanently active. This results in continuous activation of the adenylyl cyclase of intestinal epithelial cells, chronically high [cAMP], and chronically active PKA. PKA phosphorylates the CFTR <span class="math" id="dav_9781319322342_CGKnkeHfTE" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mtext>Cl</mtext><mo>−</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Cl Superscript minus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0111.png"/></annotation-xml></semantics></math></span> channel (see <a class="crossref" href="nel_9781319228002_ch11_04.xhtml#dav_9781319322342_nA90rax7c9" id="dav_9781319322342_VQ9LO20bRG">Box 11-2</a>) and a <span class="math" id="dav_9781319322342_JD9TeEfa9N" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Na</mtext></mrow><mo>+</mo></msup><msup><mrow><mtext>-H</mtext></mrow><mo>+</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Na Superscript plus Baseline hyphen upper H Superscript plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0112.png"/></annotation-xml></semantics></math></span> exchanger in the intestinal epithelial cells. The resultant efflux of NaCl triggers massive water loss through the intestine as cells respond to the ensuing osmotic imbalance. Severe dehydration and electrolyte loss are the major pathologies in cholera. These can be fatal in the absence of prompt rehydration therapy. <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_EplI3HXLUt" role="presentation" src="../images/nelsonlehnpob8e_01_pg36.png"/></p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_Vy26tIoKQi">
<img alt="A figure shows how A D P-ribosylation locks G subscript s Greek letter alpha in the active position by comparing the structures of normal G subscript s Greek letter alpha and A D P-ribosylated G subscript s Greek letter alpha." aria-describedby="dav_9781319322342_kBJFGFH0O2" class="figure" id="dav_9781319322342_ynFLHy7qIg" src="../images/nelsonlehnpob8e_12_14_301718.png"/>
<figcaption id="dav_9781319322342_y7FFA540hG">
<p class="noindent" id="dav_9781319322342_EOQYlLaC05"><span class="label" epub:type="label" id="dav_9781319322342_P5TqPRj9B4">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_a7DeunsW6X">12-14 </span><span class="title" id="dav_9781319322342_dX2Kej6h0v">ADP-ribosylation locks <span class="math" id="dav_9781319322342_X4Zc02OOqj" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mtext mathvariant="bold-italic">α</mtext></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s bold-italic alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0113.png"/></annotation-xml></semantics></math></span> in the active conformation.</span> The bacterial toxin that causes cholera is an enzyme that catalyzes transfer of the ADP-ribose moiety of <span class="math" id="dav_9781319322342_muZN67Lb3x" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>NAD</mtext></mrow><mo>+</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="NAD Superscript plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0114.png"/></annotation-xml></semantics></math></span> (nicotinamide adenine dinucleotide) to an Arg residue of <span class="math" id="dav_9781319322342_SN6DsrDIM5" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mrow><mtext>s</mtext><mi>α</mi></mrow></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s alpha" src="../images/MATH/nel_9781319228002_ch12_03EQ_0115.png"/></annotation-xml></semantics></math></span>. The G proteins thus modified fail to respond to normal hormonal stimuli. The pathology of cholera results from defective regulation of adenylyl cyclase and overproduction of cAMP.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_kBJFGFH0O2" title="hidden">
<p class="noindent" id="dav_9781319322342_9d6maiyOdH">The top part of the figure is accompanied by text reading, normal G subscript s Greek letter alpha: G T Pase activity terminates the signal from receptor to adenylyl cyclase. A green oval labeled G subscript s and Greek letter alpha has a protrusion to the upper left with a vertical tail extending up and a bond from its right side to A r g bonded to N H 2. It is added to a molecule labeled N A D plus that has the following structure. A five-membered ring has O substituted for C at position 6 at the top vertex, C 1 prime at its left side vertex bonded to N plus at the bottom vertex of a six-membered ring above and to H below, C 2 prime and C 3 prime bonded to H above and O H below, C 4 prime bonded to C 5 prime above and to H below, and C 5 prime bonded to 2 H and to O bonded to P double bonded to O above, bonded to O minus below, and bonded to P to the left double bonded to O above, bonded to O minus below, and bonded to O to the right that is further bonded to adenosine. The six-membered ring has double bonds at its upper left, lower left, and right sides, N plus substituted for C at its bottom vertex and further bonded to C 1 prime of the five-membered ring below, and its upper right vertex bonded to C double bonded to O and bonded to N H 2. A downward arrow labeled cholera toxin has an arrow branching off to show the loss of a six-membered ring that has double bonds at its upper left, lower left, and right sides, N substituted for C at its bottom vertex, and its upper right vertex bonded to C double bonded to O and bonded to N H 2. The bottom part showing the product of this reaction is accompanied by text reading, A D P-ribosylated G subscript s Greek letter alpha: G T Pase activity is inactivated; G subscript s Greek letter alpha constantly activates adenylyl cyclase. A green oval labeled G subscript s and Greek letter alpha has a protrusion to the upper left with a vertical tail extending up and a bond from its right side to A r g bonded to N bonded to C 1 prime of a five-membered ring below and to H. The rest of the molecule, beginning with the five-membered ring, is labeled A D P-ribose. It has the same structure as N A D plus above except that C 1 prime is now bonded to N H bonded to A r g bonded to the green oval instead of to N of a six-membered ring.</p>
</aside>
</section>
<section class="sect2" id="dav_9781319322342_8vO2dKyWk8">
<header id="dav_9781319322342_ZFCUzklUH0"><h4 class="b-head v3" id="dav_9781319322342_ZkXBYehj2J">Diacylglycerol, Inositol Trisphosphate, and <span class="math" id="dav_9781319322342_to5Exong1w" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mtext mathvariant="bold">Ca</mtext><mrow><mn mathvariant="bold">2</mn><mo mathvariant="bold">+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold Ca Superscript bold 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0116.png"/></annotation-xml></semantics></math></span> Have Related Roles as Second Messengers</h4></header>
<p class="noindent" id="dav_9781319322342_HlgfC4bLnq">A second broad class of GPCRs is coupled through a G protein to a plasma membrane <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_xeHNhn8MEy">phospholipase C (PLC)</dfn> that catalyzes cleavage of the membrane phospholipid phosphatidylinositol 4,5-bisphosphate, or <span class="math" id="dav_9781319322342_2Otbfa9xXK" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>PIP</mtext></mrow><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="PIP Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0117.png"/></annotation-xml></semantics></math></span> (see <a class="crossref" href="nel_9781319228002_ch10_03.xhtml#dav_9781319322342_qsjldu26Di" id="dav_9781319322342_wEsKSeEiyu">Fig. 10-14</a>). When one of the agonists (hormone, neurotransmitter, growth factor; <strong class="important" id="dav_9781319322342_D5vcMOhSXK"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_tuRGgwp23J" id="dav_9781319322342_Qac33ssFz2">Table 12-4</a></strong>) that act by this mechanism binds its specific receptor in the plasma membrane (<strong class="important" id="dav_9781319322342_udodtsmwuD"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_I9gkVdJtIb" id="dav_9781319322342_ipOKvxSRY1">Fig. 12-15</a></strong>, step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_tRaNtV2ZhZ" role="presentation" src="../images/1a.png"/>), the receptor-hormone complex catalyzes GTP-GDP exchange on an associated trimeric G protein, <span class="math" id="dav_9781319322342_mzj5A0hSiT" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext mathvariant="bold">G</mtext><mtext mathvariant="bold">q</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold upper G Subscript bold q" src="../images/MATH/nel_9781319228002_ch12_03EQ_0118.png"/></annotation-xml></semantics></math></span> (step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_2kXU10W186" role="presentation" src="../images/2.png"/>). This activates the <span class="math" id="dav_9781319322342_abg89cCaj8" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>q</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript q" src="../images/MATH/nel_9781319228002_ch12_03EQ_0119.png"/></annotation-xml></semantics></math></span> proteins in much the same way that the <i class="semantic-i" id="dav_9781319322342_ZWP4RiGiK4">β</i>-adrenergic receptor activates <span class="math" id="dav_9781319322342_PA8FyItQl2" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0120.png"/></annotation-xml></semantics></math></span> (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_J0iHLT2Ncj" id="dav_9781319322342_zArLpLTKwX">Fig. 12-4</a>). The activated <span class="math" id="dav_9781319322342_XH8KuF5tCj" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>q</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript q" src="../images/MATH/nel_9781319228002_ch12_03EQ_0121.png"/></annotation-xml></semantics></math></span> activates the <span class="math" id="dav_9781319322342_UdRDQ9Cb90" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>PIP</mtext></mrow><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="PIP Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0122.png"/></annotation-xml></semantics></math></span>-specific PLC (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_I9gkVdJtIb" id="dav_9781319322342_impQ8Y5DeG">Fig. 12-15</a>, step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_ZvmmHI1YKs" role="presentation" src="../images/3.png"/>), which catalyzes the production of two potent second messengers (step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_cANCIWjnuQ" role="presentation" src="../images/4.png"/>), <strong class="important" id="dav_9781319322342_Iia5faRSb5">diacylglycerol</strong> and <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_91PwTYq5wI">inositol 1,4,5-trisphosphate</dfn>, or <span class="math" id="dav_9781319322342_Id0hni9mIM" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext mathvariant="bold">IP</mtext><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0123.png"/></annotation-xml></semantics></math></span> (not to be confused with <span class="math" id="dav_9781319322342_fhJYxhURG6" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>PIP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="PIP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0124.png"/></annotation-xml></semantics></math></span>, <a class="crossref" href="nel_9781319228002_ch12_05.xhtml#page435" id="dav_9781319322342_qJmfSLlQij">p. 435</a> or <a class="crossref" href="nel_9781319228002_ch12_05.xhtml#dav_9781319322342_D2sm2jQsC7" id="dav_9781319322342_5NrlH4Rthx">Fig. 12-24</a>).</p>
<figure class="figure lm_img_lightbox unnum c2 center" id="dav_9781319322342_B5JZprRqzc">
<img alt="A figure shows the structure of inositol 1,4,5-triphosphate (I P subscript 3)." aria-describedby="dav_9781319322342_wSDYg1qXQ2" class="figure" id="dav_9781319322342_D9YZSyrkYc" src="../images/nelsonlehnpob8e_12_un01_301747.png"/>
</figure>
<aside class="hidden" id="dav_9781319322342_wSDYg1qXQ2" title="hidden">
<p class="noindent" id="dav_9781319322342_Z19J4VzWp0">A chair conformation of a six-membered ring is shown with all of the carbons numbered and with C 1 at the upper middle vertex. C 1 has an up-equatorial bonded to O bonded to P double bonded to O to the right and bonded to O minus above and to the left; C 2 has an up-axial bond to O H; C 3 has an up-equatorial bond to O H; C 4 has a down-equatorial bond to O bonded to P double bonded to O to the left and bonded to O minus below and to the right; C 5 has a down-equatorial bond to O bonded to P double bonded to O to the left and bonded to O minus below and to the right; and C 6 has a down-equatorial bond to O H.</p>
</aside>
<table class="table sectioned c3 main-flow" id="dav_9781319322342_tuRGgwp23J">
<caption id="dav_9781319322342_d64EAj1ljY">
<p class="noindent" id="dav_9781319322342_Bua6MbAPvw"><span class="label" epub:type="label" id="dav_9781319322342_y4vyjCAxhk">TABLE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_cYuHosw4Il">12-4 </span><span class="title" id="dav_9781319322342_tOd1YzTltE">Some Signals That Act through Phospholipase C, <span class="math" id="dav_9781319322342_v976KJb6Vy" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext mathvariant="bold">IP</mtext></mrow><mn mathvariant="bold">3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold IP Subscript bold 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0125.png"/></annotation-xml></semantics></math></span>, and <span class="math" id="dav_9781319322342_i4DzldA3hU" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext mathvariant="bold">Ca</mtext></mrow><mrow><mn mathvariant="bold">2</mn><mo mathvariant="bold">+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold Ca Superscript bold 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0126.png"/></annotation-xml></semantics></math></span></span></p>
</caption>
<tr id="dav_9781319322342_f5GJCkq39j">
<td class="left" id="dav_9781319322342_iPDdoDrXwf">Acetylcholine [muscarinic <span class="math" id="dav_9781319322342_R0IKCZLegl" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>M</mtext><mn>1</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript 1" src="../images/MATH/nel_9781319228002_ch12_03EQ_0127.png"/></annotation-xml></semantics></math></span>]</td>
<td class="left" id="dav_9781319322342_zqD9Z02X40">Gastrin-releasing peptide</td>
<td class="left" id="dav_9781319322342_SHxbP30ZKi">Platelet-derived growth factor (PDGF)</td>
</tr>
<tr id="dav_9781319322342_md6CCOWwHd">
<td class="left" id="dav_9781319322342_8MnoksL4NY"><span class="math" id="dav_9781319322342_a3t6WJ36v9" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>α</mi><mn>1</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="alpha 1" src="../images/MATH/nel_9781319228002_ch12_03EQ_0128.png"/></annotation-xml></semantics></math></span>-Adrenergic agonists</td>
<td class="left" id="dav_9781319322342_zl3yyVTB6K">Glutamate</td>
<td class="left" id="dav_9781319322342_D6QqrGUIqW">Serotonin <span class="math" id="dav_9781319322342_RvLmISkzft" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><mn>5</mn><msub><mtext>-HT</mtext><mn>2</mn></msub><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket 5 hyphen HT Subscript 2 Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0129.png"/></annotation-xml></semantics></math></span></td>
</tr>
<tr id="dav_9781319322342_lqA7dmipqZ">
<td class="left" id="dav_9781319322342_8KyDUDNCfP">Angiogenin</td>
<td class="left" id="dav_9781319322342_pUf8SDahqf">Gonadotropin-releasing hormone (GRH)</td>
<td class="left" id="dav_9781319322342_bUWcZN6iNE">Thyrotropin-releasing hormone (TRH)</td>
</tr>
<tr id="dav_9781319322342_Y5S1nHxI1E">
<td class="left" id="dav_9781319322342_FhUZE1K1O9">Angiotensin II</td>
<td class="left" id="dav_9781319322342_MBzKnOnVeH">Histamine <span class="math" id="dav_9781319322342_65oarTBNkL" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msub><mtext>H</mtext><mn>1</mn></msub><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket upper H Subscript 1 Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0130.png"/></annotation-xml></semantics></math></span></td>
<td class="left" id="dav_9781319322342_G1PlatAw8y">Vasopressin</td>
</tr>
<tr id="dav_9781319322342_CE3esX6He9">
<td class="left" id="dav_9781319322342_Tc4T79tj8k">ATP <span class="math" id="dav_9781319322342_ZwhD3klOat" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msub><mtext>P</mtext><mrow><mn>2</mn><mtext>x</mtext></mrow></msub><mo lspace="0">,</mo><msub><mtext>P</mtext><mrow><mn>2</mn><mtext>y</mtext></mrow></msub><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket upper P Subscript 2 x Baseline comma upper P Subscript 2 y Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0131.png"/></annotation-xml></semantics></math></span></td>
<td class="left" id="dav_9781319322342_OrmgE2BKh4">Light (<i class="semantic-i" id="dav_9781319322342_nu9Ls3xvNA">Drosophila</i>)</td>
<td class="left" id="dav_9781319322342_AQYn8GX0LH"/>
</tr>
<tr id="dav_9781319322342_bS7lV1pnPF">
<td class="left" id="dav_9781319322342_8iBDw5W5Lz">Auxin</td>
<td class="left" id="dav_9781319322342_nqAasx3yHy">Oxytocin</td>
<td class="left" id="dav_9781319322342_Fbzat5Wnp0"/>
</tr>
<tr id="dav_9781319322342_dJgH1ROUrD">
<td class="left" colspan="3" id="dav_9781319322342_jrPLUkRxsX">Note: Receptor subtypes are in square brackets; see footnote to <a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_jE7HcB2hLX" id="dav_9781319322342_yrgQAxj1K0">Table 12-3</a>.</td>
</tr>
</table>
<figure class="figure lm_img_lightbox num c4 center" id="dav_9781319322342_I9gkVdJtIb">
<img alt="A figure shows how hormone-activated phospholipase C and I P subscript 3 are produced and contribute to the activation of protein kinase C." aria-describedby="dav_9781319322342_evcrC837lN" class="figure" id="dav_9781319322342_jIHDOOWnPI" src="../images/nelsonlehnpob8e_12_15_301719.png"/>
<figcaption id="dav_9781319322342_OZv12m3ZH4">
<p class="noindent" id="dav_9781319322342_7mJ0vKK4qh"><span class="label" epub:type="label" id="dav_9781319322342_aYpQepjdCl">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_bvMCMjdOS8">12-15 </span><span class="title" id="dav_9781319322342_KkldDwzhID">Hormone-activated phospholipase C and <span class="math" id="dav_9781319322342_Drx77q9emd" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext mathvariant="bold-italic">IP</mtext><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold-italic IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0132.png"/></annotation-xml></semantics></math></span>.</span> Two intracellular second messengers are produced in the hormone-sensitive phosphatidylinositol system: inositol 1,4,5-trisphosphate <span class="math" id="dav_9781319322342_CqXVtcaHNL" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis IP Subscript 3 Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0133.png"/></annotation-xml></semantics></math></span> and diacylglycerol are cleaved from phosphatidylinositol 4,5-bisphosphate <span class="math" id="dav_9781319322342_7vMR7qcLNi" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msub><mrow><mtext>PIP</mtext></mrow><mn>2</mn></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis PIP Subscript 2 Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0134.png"/></annotation-xml></semantics></math></span>. Both contribute to the activation of protein kinase C. By raising cytosolic <span class="math" id="dav_9781319322342_pC5yijxe5V" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mtext>Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0135.png"/></annotation-xml></semantics></math></span>, <span class="math" id="dav_9781319322342_Jz2f5TXZk1" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0136.png"/></annotation-xml></semantics></math></span> also activates other <span class="math" id="dav_9781319322342_Ws3w6HfgAg" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0137.png"/></annotation-xml></semantics></math></span>-dependent enzymes; thus <span class="math" id="dav_9781319322342_NY1EnAUYdJ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0138.png"/></annotation-xml></semantics></math></span> also acts as a second messenger.</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_evcrC837lN" title="hidden">
<p class="noindent" id="dav_9781319322342_2N0mWx881b">A piece of cell membrane curves down from the upper left to the lower right of the illustration. Step 1: Hormone (H) binds to a specific receptor. A roughly rectangular protein labeled receptor extends across the membrane. A strand begins at the upper left and bends up and down within the receptor, running above and below a small brown hexagon with a protrusion to the upper left labeled H, and then leaves the protein at the lower left to end at C within a green oval labeled G subscript q Greek letter alpha and with a small gray oval inside labeled G D P. The oval extends to the left from its top side, where a thread extends up halfway through the membrane, and it joins a green crescent-shaped piece labeled G subscript s Greek letter gamma that has a thread extending into the membrane at its upper right side, then curves to the left, and then wraps back to the right beneath a green oval piece that fits between it and the green oval labeled G subscript q subscript Greek letter alpha and that has a small tail extending below the lower right end of the crescent. Step 2: The occupied receptor causes G D P-G T P exchange on G subscript q Greek letter alpha. An arrow pointing to the right branches to an arrow showing the low of a gray oval labeled G D P and is joined by an arrow showing the addition of an orange oval labeled G T P. Step 3: G subscript q Greek letter alpha, with bound G T P, moves to P L C and activates it. This produces a green oval labeled G subscript q Greek letter alpha with a more pointed end away from the membrane that is almost perpendicular to the membrane with a protrusion extending to the right and a thread that extends into the membrane. It also contains an orange oval labeled G T P. The crescent-shaped piece and second oval are no longer present. The protrusion to the upper right along the membrane intersects with the lower left side of a light blue pear-shaped structure labeled phospholipase C (P L C). The narrow end of P L C ends just below the outer layer of phosphate heads in the membrane. There are short radiating lines extending out all around G subscript q Greek letter alpha and P L C. Most of the phospholipids in the membrane have a blue sphere with two yellow tails. Immediately to the right of P L C, there is a red molecule labeled P I P subscript 2 with a sphere aligned with those on the inner layer of phosphate heads in the membrane and with two red tails extending into the membrane. Two arrows point away from this red molecule, one pointing to the left into the cytosol of the cell and one pointing to the right within the membrane. Step 4: Active P L C cleaves P I P subscript 2 to I P subscript 3 and diacylglycerol. The arrow running through the membrane points to a red half-circle aligned with the phosphate heads on the inner side of the membrane with two red tails extending into the membrane. This red molecule is labeled diacylglycerol. Another arrow points along the membrane to show the same red molecule with its half-circle against a blue irregular oval labeled protein kinase C with a purple C a 2 plus sphere inside and short lines radiating out from all sides. Step 5: I P subscript 3 binds to a specific receptor-gated C a 2 plus channel, releasing sequestered C a 2 plus. The arrow pointing from the red molecule of P I P 2 into the cytosol indicates a red half-circle labeled I P subscript 3 at the top of a large protein labeled C a 2 plus channel that runs through a membrane to the left labeled endoplasmic reticulum. This membrane curves through the left side of the illustration, from the center left to lower left. Part of a second C a 2 plus channel extends across the membrane as it leaves the frame. The C a 2 plus with bound I P subscript 3 is wider above the membrane and narrower within the membrane. It contains a channel that contains a purple sphere showing that C a 2 plus ions, which are abundant to the left of the channel within the endoplasmic reticulum, can move through the channel into the cytosol. An arrow points from C a 2 plus in the channel to C a 2 plus in the cytosol, from which another arrow points to the C a 2 plus within the protein kinase C molecule that is bound to diacylglycerol in the membrane. Step 6: Diacylglycerol and C a 2 plus activate protein kinase C at the surface of the plasma membrane. An arrow points from protein kinase C down to the left. Step 7: Phosphorylation of cellular proteins by protein kinase C produces some of the cellular responses to the hormone.</p>
</aside>
<p class="noindent" id="dav_9781319322342_EReoIl7Xs5">Inositol trisphosphate, a water-soluble compound, diffuses from the plasma membrane to the endoplasmic reticulum (ER), where it binds to the <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_zzmbm0Qbuy"><span class="math" id="dav_9781319322342_dIvmOzyeip" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext mathvariant="bold">IP</mtext><mn mathvariant="bold">3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold IP Subscript bold 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0139.png"/></annotation-xml></semantics></math></span>-gated <span class="math" id="dav_9781319322342_2mwBFXRnjR" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mtext mathvariant="bold">Ca</mtext><mrow><mn mathvariant="bold">2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold Ca Superscript bold 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0140.png"/></annotation-xml></semantics></math></span> channel</dfn>, causing the channel to open. The action of the SERCA pump (<a class="crossref" href="nel_9781319228002_ch11_04.xhtml#page393" id="dav_9781319322342_AFePO31pzv">pp. 393–394</a>) ensures that <span class="math" id="dav_9781319322342_hxe3yvVraI" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mtext>Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0141.png"/></annotation-xml></semantics></math></span> in the ER is orders of magnitude higher than that in the cytosol, so when these gated <span class="math" id="dav_9781319322342_mtfCDMCk6Z" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0142.png"/></annotation-xml></semantics></math></span> channels open, <span class="math" id="dav_9781319322342_J2rdy73f8k" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0143.png"/></annotation-xml></semantics></math></span> rushes into the cytosol (<a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_I9gkVdJtIb" id="dav_9781319322342_8JfmI4H3DJ">Fig. 12-15</a>, step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_B0Nb4G0cMB" role="presentation" src="../images/5.png"/>), and the cytosolic <span class="math" id="dav_9781319322342_1gS9mPFB40" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mtext>Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0144.png"/></annotation-xml></semantics></math></span> rises sharply to about <span class="math" id="dav_9781319322342_2gSpadNtu8" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mn>10</mn></mrow><mrow><mo>−</mo><mn>6</mn></mrow></msup><mtext> </mtext><mtext mathsize="0.7em">M</mtext></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="10 Superscript negative 6 Baseline upper M" src="../images/MATH/nel_9781319228002_ch12_03EQ_0145.png"/></annotation-xml></semantics></math></span>. One effect of elevated <span class="math" id="dav_9781319322342_F8gWYjOQIr" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mtext>Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0146.png"/></annotation-xml></semantics></math></span> is the activation of <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_Hq37SrqFAt">protein kinase C</dfn> (<strong class="important" id="dav_9781319322342_ZGydgVHYAq">PKC</strong>; <i class="semantic-i" id="dav_9781319322342_s6hewsAwLD">C</i> for <span class="math" id="dav_9781319322342_AoscTbNl6i" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0147.png"/></annotation-xml></semantics></math></span>). Diacylglycerol cooperates with <span class="math" id="dav_9781319322342_nItBIzaDgD" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0148.png"/></annotation-xml></semantics></math></span> in activating PKC, thus also acting as a second messenger (step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_bqPRyaJoa0" role="presentation" src="../images/6.png"/>). Activation involves the movement of a PKC domain (the pseudosubstrate domain) away from its location in the substrate-binding region of the enzyme, allowing the enzyme to bind and phosphorylate proteins that contain a PKC consensus sequence — Ser or Thr residues embedded in an amino acid sequence recognized by PKC (step <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_ruuwsbNWTF" role="presentation" src="../images/7.png"/>). <strong class="important" id="dav_9781319322342_IWrSDkdg5w"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_x2TeIuem4i" id="dav_9781319322342_SwQH1J8aei">Figure 12-16</a></strong> shows the structure of the <span class="math" id="dav_9781319322342_2YKGrsOwI7" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0149.png"/></annotation-xml></semantics></math></span> receptor and a proposed mechanism of its action as a gated <span class="math" id="dav_9781319322342_mOjavPzxOO" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0150.png"/></annotation-xml></semantics></math></span> channel.</p>
<figure class="figure lm_img_lightbox num c4 center" id="dav_9781319322342_x2TeIuem4i">
<img alt="A three-part figure shows the mechanism of action of the I P subscript 3-gated C a 2 plus channel by showing the structure of the protein in part a and by showing the model for receptor activation by I P subscript 3 in the absence of I P subscript 3 in part b and with one I P 3 bound to each subunit in part c." aria-describedby="dav_9781319322342_q9lL6H0J3I" class="figure" id="dav_9781319322342_CchbcjLk1K" src="../images/nelsonlehnpob8e_12_16_301720.png"/>
<figcaption id="dav_9781319322342_6g7xKEMfMM">
<p class="noindent" id="dav_9781319322342_KaWZlzE6xw"><span class="label" epub:type="label" id="dav_9781319322342_O1104J6IyL">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_DO6DhQuW3E">12-16 </span><span class="title" id="dav_9781319322342_hzaS71PSpc">Proposed mechanism of action of the <span class="math" id="dav_9781319322342_ffn5vFOH2B" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext mathvariant="bold">IP</mtext><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0151.png"/></annotation-xml></semantics></math></span> -gated <span class="math" id="dav_9781319322342_8EgAIwETh5" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mtext mathvariant="bold">Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0152.png"/></annotation-xml></semantics></math></span> channel. </span>(a) The <span class="math" id="dav_9781319322342_EiDtOPqJsD" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0153.png"/></annotation-xml></semantics></math></span> receptor in its closed conformation, determined by cryo-EM. The 1.3 MDa tetramer has 24 transmembrane helices that surround a central pore. The bulk of the protein protrudes out of the ER into the cytosol and contains the <span class="math" id="dav_9781319322342_tOTV5Y1AHc" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0154.png"/></annotation-xml></semantics></math></span>-binding sites. The central pore is the channel for <span class="math" id="dav_9781319322342_Bnt26dSaJb" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0155.png"/></annotation-xml></semantics></math></span> movement, which does not conduct <span class="math" id="dav_9781319322342_WwaT7xctQg" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0156.png"/></annotation-xml></semantics></math></span> in the absence of <span class="math" id="dav_9781319322342_OFPZHTkV4j" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0157.png"/></annotation-xml></semantics></math></span>. (b, c) Model for receptor activation by <span class="math" id="dav_9781319322342_5DLF4RoaXb" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0158.png"/></annotation-xml></semantics></math></span>, showing only two of the four identical subunits (b) in the absence of <span class="math" id="dav_9781319322342_xQzQgxdzo8" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0159.png"/></annotation-xml></semantics></math></span>, and (c) with one <span class="math" id="dav_9781319322342_m7k1Xw84UM" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0160.png"/></annotation-xml></semantics></math></span> bound to each subunit. According to this model, <span class="math" id="dav_9781319322342_sxF0GTl4pQ" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0161.png"/></annotation-xml></semantics></math></span> binding near the amino-terminal end of a subunit causes a major rearrangement of the <i class="semantic-i" id="dav_9781319322342_JB5fiyFyjJ">α</i> helix at the carboxyl-terminal end, opening the <span class="math" id="dav_9781319322342_gk7wwxTkh8" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0162.png"/></annotation-xml></semantics></math></span> channel. [(a) Data from PDB ID 6MU2, G. Fan et al., <i class="semantic-i" id="dav_9781319322342_jTPLiAK9KX">Cell Res.</i> 28:1158, 2018. (b, c) Information from M. J. Berridge, <i class="semantic-i" id="dav_9781319322342_MJK7ZlCFiY">Physiol. Rev</i>. 96:1261, 2016, Fig. 3.]</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_q9lL6H0J3I" title="hidden">
<p class="noindent" id="dav_9781319322342_zAnR7plUwi">A horizontal membrane is shown with the area above labeled as cytosol and the area below labeled as lumen. Part a shows two views of the I P subscript 3-gated C a 2 plus channel. The first view shows four similar subunits that each contain many helices in a spherical region that thins on one side to produce a curved tail. The red subunit on the left has its spherical region to the right with its tail to the left. A small piece of yellow extends up into its lower right side, where it has a small red protrusion into the green sphere to its right. Each of the pieces is similar with green at the top, blue at the right side, and yellow below. This is shown rotated 90 degrees with the yellow subunit in front. The entire structure is much wider above the membrane in the cytosol than in the part that crosses the membrane into the E R lumen. The yellow subunit has a “C”-shaped piece with a horizontal piece extending from its left side across the open region of the “C” and with a vertical piece extending down across the membrane with a small piece of the blue subunit from the right separating the yellow piece at the bottom as it emerges from the membrane. The red subunit is on the left, the green subunit is barely visible at the back, and the blue subunit is on the right. Part b shows a set of five vertical cylinders that extend through the membrane and that alternate being slightly higher or lower. The left-hand cylinder has a thread extending above with many loops. One loop above and slightly to the left has four circles labeled minus and another loop, in the center above the right side of the five vertical light red cylinders, has four circles labeled plus just above where the strand ends at N. The left-hand cylinder has a loop to the bottom of the second cylinder, which has a loop from its top to the top of the third cylinder, which has a loop from its bottom to the bottom of the fourth cylinder, which has a loop from its top to the top of the fifth cylinder, which has a loop from its bottom to a short bent light red vertical cylinder that crosses the very bottom of the membrane with a dashed arrow between it and a similar blue cylinder bent in the opposite direction. The light red bent vertical cylinder has a strand connecting it to a longer cylinder that crosses the membrane at a diagonal to emerge just above the dashed arrow below. Its top crosses the top of a similar blue cylinder extending up from the lower right. Strands from the blue and light red cylinders intertwine above them to end at C. This blue cylinder has a loop connecting to the small bent blue cylinder below, which connects to the first of five vertical cylinders arranged similarly to the light red cylinders on the left and also connected by loops above and below. The right-hand blue cylinder has a strand extending from its top that loops like the one from the left-hand light red cylinder, with similar patterns of circles with minus and plus signs. Many purple spheres labeled C a 2 plus are in the E R lumen and a dashed arrow from one points between the two small bent cylinders and into a rounded opening formed when the long light red and blue cylinders intersect. An arrow labeled I P subscript 3 end subscript R activation points right to part c. Part c shows a similar structure to the one in part c except that the small bent cylinders are now straight and vertical and the long diagonal cylinders that had intersected are now almost vertical. The strands above the long diagonal cylinders are now separate instead of intertwined. The left and right regions with circles with minus signs now each wrap around a purple C a 2 plus sphere and the regions with circles with minus signs now wrap around I P subscript 3 molecules. Each I P subscript 3 molecule has a chair conformation of a six-membered ring with an up-axial bond from the upper left vertex, an up-equatorial bond to P from the upper middle vertex, an up-equatorial bond from the upper right vertex, an up-equatorial bond to P from the lower right vertex, a down-equatorial bond to P from the lower middle vertex, and a down-equatorial bond from the lower left vertex.</p>
</aside>
<p class="indent" id="dav_9781319322342_o6nWx6az6L">Several isozymes of PKC are known, each with a characteristic tissue distribution, target protein specificity, and role. PLC<i class="semantic-i" id="dav_9781319322342_vNBThJ8Efa">β</i> is activated by GPCRs; another isoform, PLC<i class="semantic-i" id="dav_9781319322342_aAFBXLWsA9">γ</i>, is activated by receptor tyrosine kinases, as described below. The ultimate PKC targets include cytoskeletal proteins, enzymes, and nuclear proteins that regulate gene expression. Taken together, this family of enzymes has a wide range of cellular actions, affecting neuronal and immune function and the regulation of cell division. Compounds that lead to overexpression of PKC or that increase its activity to abnormal levels act as tumor promoters; animals exposed to these substances have increased rates of cancer.</p>
</section>
<section class="sect2" id="dav_9781319322342_AhIzaTmZNz">
<header id="dav_9781319322342_60cSNly49Y"><h4 class="b-head v3" id="dav_9781319322342_QgeWIn0myl">Calcium Is a Second Messenger That Is Limited in Space and Time</h4></header>
<p class="noindent" id="dav_9781319322342_KiyxKNFCiY">There are many variations on this basic scheme for <span class="math" id="dav_9781319322342_XJrgDJXnnb" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0163.png"/></annotation-xml></semantics></math></span> signaling. In many cell types that respond to extracellular signals, <span class="math" id="dav_9781319322342_MrTcSTDmrm" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0164.png"/></annotation-xml></semantics></math></span> serves as a second messenger that triggers intracellular responses, such as exocytosis in neurons and endocrine cells, contraction in skeletal muscle, and cytoskeletal rearrangements during amoeboid movement. In unstimulated cells, cytosolic <span class="math" id="dav_9781319322342_sz01oo2fHA" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mtext>Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0165.png"/></annotation-xml></semantics></math></span> is kept very low <span aria-label="426" epub:type="pagebreak" id="page426" role="doc-pagebreak"/><span class="math" id="dav_9781319322342_gwlLAHpySz" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><mo lspace="0" rspace="0">&lt;</mo><msup><mrow><mn>10</mn></mrow><mrow><mo>−</mo><mn>7</mn></mrow></msup><mtext> </mtext><mtext>M</mtext><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis less-than 10 Superscript negative 7 Baseline upper M right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0166.png"/></annotation-xml></semantics></math></span> by the action of <span class="math" id="dav_9781319322342_ZdyW9SYVer" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0167.png"/></annotation-xml></semantics></math></span> pumps in the ER, mitochondria, and plasma membrane (as further discussed below). <img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_KTKw5XiZsO" role="presentation" src="../images/nelsonlehnpob8e_PG03.png"/> Hormonal, neural, or other stimuli cause either an influx of <span class="math" id="dav_9781319322342_gignvPGHbL" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0168.png"/></annotation-xml></semantics></math></span> into the cell through specific <span class="math" id="dav_9781319322342_4E3rWPADs5" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0169.png"/></annotation-xml></semantics></math></span> channels in the plasma membrane or the release of sequestered <span class="math" id="dav_9781319322342_0GBQqWlpgd" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0170.png"/></annotation-xml></semantics></math></span> from the ER or mitochondria, in either case raising the cytosolic <span class="math" id="dav_9781319322342_Z0GDShxL1T" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mtext>Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0171.png"/></annotation-xml></semantics></math></span> and triggering a cellular response.</p>
<p class="indent" id="dav_9781319322342_MRk2WFpT9P">Changes in intracellular <span class="math" id="dav_9781319322342_We6XoagZw8" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mtext>Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0172.png"/></annotation-xml></semantics></math></span> are detected by <span class="math" id="dav_9781319322342_3R1ymDyZ8f" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0173.png"/></annotation-xml></semantics></math></span>-binding proteins that regulate a variety of <span class="math" id="dav_9781319322342_Spc9SIW8tk" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0174.png"/></annotation-xml></semantics></math></span>-dependent enzymes. <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_72P0RkujOi">Calmodulin</dfn> (<strong class="important" id="dav_9781319322342_B7OspupmgS">CaM</strong>; <span class="math" id="dav_9781319322342_HZkuw7BxEf" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>M</mi><mtext>r</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper M Subscript r" src="../images/MATH/nel_9781319228002_ch12_03EQ_0175.png"/></annotation-xml></semantics></math></span> 17,000) is an acidic protein with four high-affinity <span class="math" id="dav_9781319322342_NH6MBBCBhB" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0176.png"/></annotation-xml></semantics></math></span>-binding sites (<span class="math" id="dav_9781319322342_JOKpdlakjY" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mi>K</mi><mtext>d</mtext></msub><mo>≈</mo><mn>0.1</mn></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper K Subscript d Baseline almost-equals 0.1" src="../images/MATH/nel_9781319228002_ch12_03EQ_0177.png"/></annotation-xml></semantics></math></span> to 1 <i class="semantic-i" id="dav_9781319322342_TaracHiV3k">μ</i><span class="smallcap" id="dav_9781319322342_iwf95tBCqo">m</span>) (<strong class="important" id="dav_9781319322342_soFfIsOuQL"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_S1tpclMwYk" id="dav_9781319322342_wRNfWdPv9t">Fig. 12-17</a></strong>). When intracellular <span class="math" id="dav_9781319322342_Th7xTM9bUk" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0178.png"/></annotation-xml></semantics></math></span> rises to about <span class="math" id="dav_9781319322342_k8tu555M2k" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mn>10</mn></mrow><mrow><mo>−</mo><mn>6</mn></mrow></msup><mtext> </mtext><mtext>M</mtext></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="10 Superscript negative 6 Baseline upper M" src="../images/MATH/nel_9781319228002_ch12_03EQ_0179.png"/></annotation-xml></semantics></math></span> (1 <i class="semantic-i" id="dav_9781319322342_tnESn1jzMr">μ</i><span class="smallcap" id="dav_9781319322342_dG2x5LRIVv">m</span>), the binding of <span class="math" id="dav_9781319322342_Tca60XXSKq" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0180.png"/></annotation-xml></semantics></math></span> to calmodulin drives a conformational change in the protein. Calmodulin associates with a variety of proteins and, in its <span class="math" id="dav_9781319322342_ID2pA5cOJr" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0181.png"/></annotation-xml></semantics></math></span>-bound state, modulates their activities. It is a member of a family of <span class="math" id="dav_9781319322342_3aY3HeFwZU" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0182.png"/></annotation-xml></semantics></math></span>-binding proteins that also includes troponin (see <a class="crossref" href="nel_9781319228002_ch05_04.xhtml#dav_9781319322342_S2aBEctuzv" id="dav_9781319322342_OXq60QM8sZ">Fig. 5-30</a>), which triggers skeletal muscle contraction in response to increased <span class="math" id="dav_9781319322342_D0pWjaddwz" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0183.png"/></annotation-xml></semantics></math></span>. Members of this family share a characteristic <span class="math" id="dav_9781319322342_8Cy42jNHZm" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0184.png"/></annotation-xml></semantics></math></span>-binding structure, the EF hand.</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_S1tpclMwYk">
<img alt="A three-part figure shows a ribbon model of the crystal structure of calmodulin with four occupied high-affinity C a 2 plus binding sites, part b with ribbon models showing the interaction between calmodulin and calmodulin-dependent protein kinase, and part c showing the helix-loop-helix motif called E F hand that contains the C a 2 plus binding sites." aria-describedby="dav_9781319322342_Yaadyu2S11" class="figure" id="dav_9781319322342_SEWjoCkCj7" src="../images/nelsonlehnpob8e_12_17_301721.png"/>
<figcaption id="dav_9781319322342_A2zZlLYWEh">
<p class="noindent" id="dav_9781319322342_CFJFHc7zky"><span class="label" epub:type="label" id="dav_9781319322342_XgOMg4gOgZ">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_yLXrlp13E0">12-17 </span><span class="title" id="dav_9781319322342_WpsghNvQcM">Calmodulin, the protein mediator of many <span class="math" id="dav_9781319322342_5lSlJUNniR" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mtext mathvariant="bold">Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0185.png"/></annotation-xml></semantics></math></span>-stimulated enzymatic reactions. </span>(a) In this ribbon model of the crystal structure of calmodulin, the four high-affinity <span class="math" id="dav_9781319322342_5JgejqiRTR" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0186.png"/></annotation-xml></semantics></math></span>-binding sites are occupied by <span class="math" id="dav_9781319322342_KDvTb7o743" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0187.png"/></annotation-xml></semantics></math></span> (purple). The amino-terminal domain is on the left; the carboxyl-terminal domain on the right. (b) Calmodulin associated with a helical domain of one of the many enzymes it regulates, calmodulin-dependent protein kinase II. Notice that the long central <i class="semantic-i" id="dav_9781319322342_8Zc3tMsbi1">α</i> helix of calmodulin visible in (a) has bent back on itself in binding to the helical substrate domain. The central helix of calmodulin is clearly more flexible in solution than in the crystal. (c) Each of the four <span class="math" id="dav_9781319322342_belmvNJNxr" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0188.png"/></annotation-xml></semantics></math></span>-binding sites occurs in a helix-loop-helix motif called the EF hand, found in many <span class="math" id="dav_9781319322342_4exUB2qyKb" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0189.png"/></annotation-xml></semantics></math></span>-binding proteins. [Data from (a) PDB ID 1CLL, R. Chattopadhyaya et al., <i class="semantic-i" id="dav_9781319322342_5gTPiF6Ml7">J. Mol. Biol.</i> 228:1177, 1992; (b, c) PDB ID 1CDL, W. E. Meador et al., <i class="semantic-i" id="dav_9781319322342_xG8rf6SIYX">Science</i> 257:1251, 1992.]</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_Yaadyu2S11" title="hidden">
<p class="noindent" id="dav_9781319322342_Wu1HwvU6Ep">Part a shows a ribbon structure with a long brown helix labeled long central helix that runs almost horizontally. A vertical green helix runs behind the left side of the long brown helix and a short green helix runs in front of it slower half. A horizontal helix behind this short green helix runs to the left, where there are beta strands and threads that loop around two purple spheres to the lower left of the long central helix. A short purple helix runs from below the left end long central helix to intersect the long central helix slightly to the left. It does not extend above the long central helix. A second purple helix begins below the right end of the long central helix and extends up to the right, where it runs in front of another short purple helix that extends above the long central helix. To the lower right of the long central helix, in loops extending down from the purple helices, there are two purple spheres. Part b shows the same helices but the long central helix has bent and the overall structure is now more spherical. The green helices form the left side and a small piece of the long central helix runs across the upper part. The two purple spheres associated with the green helices are more spread out amongst the threads on the center of the left side. The purple helices form the right side except for one that runs horizontally across the bottom of the structure to meet the green helices. A longer piece of the long central helix runs vertically across the left of this purple side and has a strand connecting it to the shorter piece of the long central helix on the left. The two purple spheres associated with the purple helices are more spread out amongst the threads on the right side. A helix in the open region in the center of this structure extends away from the viewer and is labeled, helical domain of a calmodulin-regulated protein. Part c shows an E F hand. A brown piece of long central helix that runs from the lower right to the upper right is labeled E helix. At its bottom end, there is a strand with several sticks extending from it to show the piece that interact with a purple sphere. Two sticks on the left are blue and orange and two on the right are orange. The stand connected to a beta strand pointing down that joins to a short horizontal helix labeled F helix. A right hand is shown with the thumb and forefinger extended and the other fingers folded down and with a purple sphere labeled C a 2 plus shown at the base of the forefinger.</p>
</aside>
<p class="indent" id="dav_9781319322342_gw20tYFFe5">Calmodulin is a subunit of the <dfn class="keyword" epub:type="keyword" id="dav_9781319322342_KhamNuFgQn"><span class="math" id="dav_9781319322342_dOkUKDf1vj" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mtext mathvariant="bold">Ca</mtext><mrow><mn mathvariant="bold">2</mn><mo mathvariant="bold">+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold Ca Superscript bold 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0190.png"/></annotation-xml></semantics></math></span>/calmodulin-dependent protein kinases (CaM kinases</dfn>, types I through IV). When intracellular <span class="math" id="dav_9781319322342_LmD8h1IKja" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0191.png"/></annotation-xml></semantics></math></span> increases in response to a stimulus, calmodulin binds <span class="math" id="dav_9781319322342_pWdwReTeuB" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0192.png"/></annotation-xml></semantics></math></span>, undergoes a change in conformation, and activates the CaM kinase. The kinase <span aria-label="427" epub:type="pagebreak" id="page427" role="doc-pagebreak"/>then phosphorylates target enzymes, regulating their activities. Calmodulin is also a regulatory subunit of phosphorylase <i class="semantic-i" id="dav_9781319322342_qePRM1LIPp">b</i> kinase of muscle, which is activated by <span class="math" id="dav_9781319322342_ieKuUXdBFl" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0193.png"/></annotation-xml></semantics></math></span>. Thus <span class="math" id="dav_9781319322342_lvwfxQboC6" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0194.png"/></annotation-xml></semantics></math></span> triggers ATP-requiring muscle contractions while also activating glycogen breakdown, providing fuel for ATP synthesis. Many other enzymes are known to be modulated by <span class="math" id="dav_9781319322342_kB7tt66mWP" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0195.png"/></annotation-xml></semantics></math></span> through calmodulin (<strong class="important" id="dav_9781319322342_QAuusLMibt"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_DtNJ522Yez" id="dav_9781319322342_AR8IPuiaTw">Table 12-5</a></strong>). The activity of the second messenger <span class="math" id="dav_9781319322342_qXFjFhGQAn" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0196.png"/></annotation-xml></semantics></math></span>, like that of cAMP, can be spatially restricted; after its release triggers a local response, <span class="math" id="dav_9781319322342_rqfq5lABnm" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0197.png"/></annotation-xml></semantics></math></span> is generally removed before it can diffuse to distant parts of the cell.</p>
<table class="table sectioned c3 main-flow" id="dav_9781319322342_DtNJ522Yez">
<caption id="dav_9781319322342_ov30YsvLpK">
<p class="noindent" id="dav_9781319322342_EwhnBJcid4"><span class="label" epub:type="label" id="dav_9781319322342_tgn6sxKvNc">TABLE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_OibBzwXP1c">12-5 </span><span class="title" id="dav_9781319322342_ppMchGLZIV">Some Proteins Regulated by <span class="math" id="dav_9781319322342_pkkKFHIx71" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mtext mathvariant="bold">C</mtext><msup><mtext mathvariant="bold">a</mtext><mrow><mn mathvariant="bold">2</mn><mo mathvariant="bold">+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="bold upper C bold a Superscript bold 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0198.png"/></annotation-xml></semantics></math></span> and Calmodulin</span></p>
</caption>
<tr id="dav_9781319322342_iAxMwWUfoF">
<td class="left" id="dav_9781319322342_mXQBeE4Kol">Adenylyl cyclase (brain)</td>
</tr>
<tr id="dav_9781319322342_lknrn4x1wr">
<td class="left" id="dav_9781319322342_n0hAtprzgV"><span class="math" id="dav_9781319322342_m5aD923i5A" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0199.png"/></annotation-xml></semantics></math></span>/calmodulin-dependent protein kinases (CaM kinases I to IV)</td>
</tr>
<tr id="dav_9781319322342_dxIlfxMGZ1">
<td class="left" id="dav_9781319322342_YtjwRWfQIo"><span class="math" id="dav_9781319322342_N443zPKkSU" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0200.png"/></annotation-xml></semantics></math></span>-dependent <span class="math" id="dav_9781319322342_BOwvOpSvUv" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Na</mtext></mrow><mo>+</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Na Superscript plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0201.png"/></annotation-xml></semantics></math></span> channel (<i class="semantic-i" id="dav_9781319322342_ckaOxtmdlM">Paramecium</i>)</td>
</tr>
<tr id="dav_9781319322342_mMagnI3emZ">
<td class="left" id="dav_9781319322342_n2nEZJwoi1"><span class="math" id="dav_9781319322342_EjvNM2uP5G" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0202.png"/></annotation-xml></semantics></math></span>-release channel of sarcoplasmic reticulum</td>
</tr>
<tr id="dav_9781319322342_36yF8oePHG">
<td class="left" id="dav_9781319322342_WdJvHJx6oo">Calcineurin (phosphoprotein phosphatase 2B)</td>
</tr>
<tr id="dav_9781319322342_wxvUICQX4V">
<td class="left" id="dav_9781319322342_ONJfvR4h6a">cAMP phosphodiesterase</td>
</tr>
<tr id="dav_9781319322342_4ghcE1aAFC">
<td class="left" id="dav_9781319322342_5X0hJ6aex5">cAMP-gated olfactory channel</td>
</tr>
<tr id="dav_9781319322342_8QlmrJ43zq">
<td class="left" id="dav_9781319322342_fPANTPQTPg">cGMP-gated <span class="math" id="dav_9781319322342_2QS1pqm25Z" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Na</mtext></mrow><mo>+</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Na Superscript plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0203.png"/></annotation-xml></semantics></math></span>, <span class="math" id="dav_9781319322342_gqkACNvukv" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0204.png"/></annotation-xml></semantics></math></span> channels (rod and cone cells)</td>
</tr>
<tr id="dav_9781319322342_xGAOXPXNXu">
<td class="left" id="dav_9781319322342_PQYQDRyTwA">Glutamate decarboxylase</td>
</tr>
<tr id="dav_9781319322342_XBxaJo5zLF">
<td class="left" id="dav_9781319322342_UV9UjVQDEa">Myosin light-chain kinases</td>
</tr>
<tr id="dav_9781319322342_39EbJZ13xl">
<td class="left" id="dav_9781319322342_Pbyj7vJ0F8"><span class="math" id="dav_9781319322342_kYBR9thE7i" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>NAD</mtext></mrow><mo>+</mo></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="NAD Superscript plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0205.png"/></annotation-xml></semantics></math></span> kinase</td>
</tr>
<tr id="dav_9781319322342_AvPW7nxW0k">
<td class="left" id="dav_9781319322342_XCCZqjXpmo">Nitric oxide synthase</td>
</tr>
<tr id="dav_9781319322342_Mqy6pF7mBQ">
<td class="left" id="dav_9781319322342_iXvOkTWbMk">Phosphatidylinositol 3-kinase</td>
</tr>
<tr id="dav_9781319322342_ymzUKhVc1q">
<td class="left" id="dav_9781319322342_6sRj6Kxi62">Plasma membrane <span class="math" id="dav_9781319322342_QKUKCzGnf6" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0206.png"/></annotation-xml></semantics></math></span> ATPase (<span class="math" id="dav_9781319322342_WlcCqZqdVI" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0207.png"/></annotation-xml></semantics></math></span> pump)</td>
</tr>
<tr id="dav_9781319322342_jvVLkpFMi9">
<td class="left" id="dav_9781319322342_WdFj3n2pSK">RNA helicase (p68)</td>
</tr>
</table>
<p class="indent" id="dav_9781319322342_b7xu3kPPtH"><span aria-label="428" epub:type="pagebreak" id="page428" role="doc-pagebreak"/>Commonly, <span class="math" id="dav_9781319322342_TTWYiVoJZM" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0208.png"/></annotation-xml></semantics></math></span> level does not simply rise and then fall, but rather oscillates with a period of a few seconds (<strong class="important" id="dav_9781319322342_uuFFJifs8C"><a class="crossref" href="nel_9781319228002_ch12_03.xhtml#dav_9781319322342_FyCeTF5Qm7" id="dav_9781319322342_wBUK6Mx0hz">Fig. 12-18</a></strong>) — even when the extracellular concentration of the triggering hormone remains constant. The mechanism underlying <span class="math" id="dav_9781319322342_9qTbQDRhBI" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0209.png"/></annotation-xml></semantics></math></span> oscillations presumably entails feedback regulation by <span class="math" id="dav_9781319322342_yTZGQg2rlk" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0210.png"/></annotation-xml></semantics></math></span> on some part of the <span class="math" id="dav_9781319322342_EXgqKSzLr6" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0211.png"/></annotation-xml></semantics></math></span>-release process. Whatever the mechanism, the effect is that one kind of signal (hormone concentration, for example) is converted into another (frequency and amplitude of intracellular <span class="math" id="dav_9781319322342_XX10dEa4pG" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0212.png"/></annotation-xml></semantics></math></span> “spikes”). The <span class="math" id="dav_9781319322342_1yr0DdbOuq" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0213.png"/></annotation-xml></semantics></math></span> signal diminishes as <span class="math" id="dav_9781319322342_jGfwvMJ20x" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0214.png"/></annotation-xml></semantics></math></span> diffuses away from the initial source (the <span class="math" id="dav_9781319322342_DFq4kbrz3M" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0215.png"/></annotation-xml></semantics></math></span> channel), is sequestered in the ER, or is pumped out of the cell.</p>
<figure class="figure lm_img_lightbox num c3 main-flow" id="dav_9781319322342_FyCeTF5Qm7">
<img alt="A two-part figure shows the appearance of thymus cells stimulated with extracellular A T P, dyed with fura, and viewed using fluorescence microscopy in part a and a graph of cytosolic [C a 2 plus] (n M) plotted against time (s) in part b." aria-describedby="dav_9781319322342_Ekw9Et5QG1" class="figure" id="dav_9781319322342_glRBmRi540" src="../images/nelsonlehnpob8e_12_18ab_277038.png"/>
<figcaption id="dav_9781319322342_vIDrCVIXf2">
<p class="noindent" id="dav_9781319322342_lcliklDAdp"><span class="label" epub:type="label" id="dav_9781319322342_gsgtRSoph3">FIGURE </span><span class="ordinal" epub:type="ordinal" id="dav_9781319322342_sW4CQxuLbx">12-18 </span><span class="title" id="dav_9781319322342_xIbUlEA8RB">Triggering of oscillations in intracellular <span class="math" id="dav_9781319322342_NhsfkC2Kak" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mtext mathvariant="bold">Ca</mtext><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket bold Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0216.png"/></annotation-xml></semantics></math></span> by extracellular signals. </span><strong class="important" id="dav_9781319322342_7TfL9ZHi1m">(a) </strong>The dye fura, which undergoes fluorescence changes when it binds <span class="math" id="dav_9781319322342_rsYfr8RVHN" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0217.png"/></annotation-xml></semantics></math></span>, can be used with fluorescence microscopy to measure the instantaneous <span class="math" id="dav_9781319322342_SP7gPL4pSO" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0218.png"/></annotation-xml></semantics></math></span> in cells. The color scale relates fluorescence intensity to <span class="math" id="dav_9781319322342_5kbrZe2ZkV" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0219.png"/></annotation-xml></semantics></math></span>. Here, thymus cells have been stimulated with extracellular ATP, which raises their internal <span class="math" id="dav_9781319322342_wRH4JVSMnL" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0220.png"/></annotation-xml></semantics></math></span>. The cells are heterogeneous in their responses: some have high intracellular <span class="math" id="dav_9781319322342_lGCX2SlzwY" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0221.png"/></annotation-xml></semantics></math></span> (red), others have much lower <span class="math" id="dav_9781319322342_vS0NQGQ7PN" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0222.png"/></annotation-xml></semantics></math></span> (blue). (b) When such a probe is used in a single hepatocyte, the agonist norepinephrine (added at the arrow) causes oscillations of <span class="math" id="dav_9781319322342_GsblQAHD6t" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0223.png"/></annotation-xml></semantics></math></span> from 200 to 500 n<span class="smallcap" id="dav_9781319322342_sRCG2ZiNYH">m</span>. Similar oscillations are induced in other cell types by other extracellular signals. [(a) Courtesy Michael D. Cahalan, University of California, Irvine, Department of Physiology and Biophysics. (b) Data from T. A. Rooney et al., <i class="semantic-i" id="dav_9781319322342_t22W0dquOD">J. Biol. Chem.</i> 264:17,131, 1989.]</p>
</figcaption>
</figure>
<aside class="hidden" id="dav_9781319322342_Ekw9Et5QG1" title="hidden">
<p class="noindent" id="dav_9781319322342_Kh3C5dPTkr">Part a shows many brightly colored spheres against a black background. A scale below shows colored associated with [C a 2 plus] (mu M) ranging from 0 to 1.0. The colors change from dark blue representing 0 to a narrow band of light blue at 0.3, to a green region, to a narrow yellow band at 0.7, to a red region. The picture shows many dark blue spheres with 7 light blue spheres, about 4 greenish spheres, and 24 spheres with grains of red, orange, yellow, and green. Part b shows a graph that plots cytosolic [C a 2 plus] (n M) on the vertical axis, ranging from 100 to 600 and labeled in increments of 100, against time (s) on the horizontal axis, ranging from 0 to 400 and labeled in increments of 100. An irregular horizontal line begins at (0, 200) and waves slightly as it runs past a downward arrow at (70, 204) before forming a sharp peak at (60, 540). It drops back to (70, 215), then rises sharply from (115, 204), to peak at (120, 535), then drops back to (135, 205), runs horizontally, then rises sharply from (175, 205) to peak at (200, 530), then drops to (210, 205), runs horizontally, then rises sharply from (255, 205) to peak at (260, 525), then drops back to (275, 205), runs horizontally, then rises sharply from (320, 205) to peak at (325, 520), before dropping back to (330, 520) to run almost horizontally to end at (380, 205). All data are approximate.</p>
</aside>
<p class="indent" id="dav_9781319322342_YDIITeZOVd">There is significant cross talk between the <span class="math" id="dav_9781319322342_KNp3oHV2C9" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0224.png"/></annotation-xml></semantics></math></span> and cAMP signaling systems. In some tissues, both the enzyme that produces cAMP (adenylyl cyclase) and the enzyme that degrades cAMP (phosphodiesterase) are stimulated by <span class="math" id="dav_9781319322342_u1HxxLz0qn" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0225.png"/></annotation-xml></semantics></math></span>. Temporal and spatial changes in <span class="math" id="dav_9781319322342_Y6JWeBcoQ0" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0226.png"/></annotation-xml></semantics></math></span> can therefore produce transient, localized changes in [cAMP]. We have noted already that PKA, the enzyme that responds to cAMP, is often part of a highly localized supramolecular complex assembled on scaffold proteins such as AKAPs. This subcellular localization of target enzymes, combined with temporal and spatial gradients in <span class="math" id="dav_9781319322342_4Qu3RwszNX" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0227.png"/></annotation-xml></semantics></math></span> and [cAMP], allows a cell to respond to one or several signals with subtly nuanced metabolic changes.</p>
</section>
<section class="summary" id="dav_9781319322342_RnRLxwvLKI">
<header id="dav_9781319322342_fyY8OdE2pm"><h4 class="title v3" epub:type="title" id="dav_9781319322342_57MbEd6efB">SUMMARY 12.2 <i class="semantic-i" id="dav_9781319322342_SzM25aPxZh">G Protein–Coupled Receptors and Second Messengers</i></h4></header>
<ul class="ul-no-mark" id="dav_9781319322342_G0dIl5sWOd">
<li id="dav_9781319322342_r0K1skbfGT"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_0Q5JpfmvDd" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> G protein–coupled receptors (GPCRs) have seven transmembrane helices and act through heterotrimeric G proteins. Ligand binding activates the G protein, which then stimulates or inhibits the activity of an effector enzyme, changing the local concentration of its second-messenger product cAMP.</li>
<li id="dav_9781319322342_YHCHgEtEq9"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_lK0CJsolal" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> Epinephrine, acting through its GPCR and the <span class="math" id="dav_9781319322342_z9qGRpu4SF" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0228.png"/></annotation-xml></semantics></math></span> protein, stimulates adenylyl cyclase, which produces cAMP. Cyclic AMP activates protein kinase A (PKA), which then phosphorylates target proteins on a Ser or Thr residue, changing their biological activity.</li>
<li id="dav_9781319322342_iwTaOkYCkn"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_q6p77Pq3zx" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> To end the response to epinephrine, a phosphodiesterase breaks down cAMP, and the G protein is inactivated by its own GTPase activity. Phosphoprotein phosphatases reverse the effects of PKA.</li>
<li id="dav_9781319322342_rBURepQwqq"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_KZlkqprpnY" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> When the epinephrine signal persists, <i class="semantic-i" id="dav_9781319322342_3lAnu2jT8B">β</i>-adrenergic receptor–specific protein kinase phosphorylates the GPCR, creating a binding site for the protein <i class="semantic-i" id="dav_9781319322342_y14VOhbBwZ">β</i>-arrestin, which prevents interaction between the GPCR and its G protein. Arrestin triggers desensitization by movement of the receptor into intracellular vesicles.</li>
<li id="dav_9781319322342_42Muc0lEhi"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_YBgb3FB7XL" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> GPCRs typically have their effects through the G protein-cAMP-PKA pathway; some act through <span class="math" id="dav_9781319322342_FxXosjuZ5I" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>s</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript s" src="../images/MATH/nel_9781319228002_ch12_03EQ_0229.png"/></annotation-xml></semantics></math></span>, raising [cAMP], others through <span class="math" id="dav_9781319322342_NptXuB9FK3" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mtext>G</mtext><mtext>i</mtext></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="upper G Subscript i" src="../images/MATH/nel_9781319228002_ch12_03EQ_0230.png"/></annotation-xml></semantics></math></span>, lowering [cAMP]. Adaptor proteins such as AKAPs tether PKA and limit its area of action and its target proteins.</li>
<li id="dav_9781319322342_hebpdxktsJ"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_gEelT6EYCt" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> Trimeric G proteins coupled to GPCRs are activated when their bound GDP is exchanged for GTP, and they remain active until their GTPase converts bound GTP to GDP. Their GTPase activity is modulated by GTPase activator proteins (GAPs) and regulators of G-protein signaling (RGSs).</li>
<li id="dav_9781319322342_6W8858HTg1"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_6vWt30V7Lu" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> Monomeric (small) G proteins such as Ras, Rab, and Ran also serve as self-limiting switches. Defective G-protein signaling is common in individuals with some types of cancer.</li>
<li id="dav_9781319322342_yB6W2ILIDX"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_wLDQxUGDUE" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> Some GPCRs are coupled to a G protein <span class="math" id="dav_9781319322342_p1M1dlhlRt" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">(</mo><msub><mtext>G</mtext><mtext>q</mtext></msub><mo stretchy="false">)</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-parenthesis upper G Subscript q Baseline right-parenthesis" src="../images/MATH/nel_9781319228002_ch12_03EQ_0231.png"/></annotation-xml></semantics></math></span> that acts through a plasma membrane phospholipase C that cleaves <span class="math" id="dav_9781319322342_L7MHv4pMFX" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>PIP</mtext></mrow><mn>2</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="PIP Subscript 2" src="../images/MATH/nel_9781319228002_ch12_03EQ_0232.png"/></annotation-xml></semantics></math></span> to diacylglycerol and <span class="math" id="dav_9781319322342_XzPT4VrGvI" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0233.png"/></annotation-xml></semantics></math></span>. By opening <span class="math" id="dav_9781319322342_USNGF7oFjh" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0234.png"/></annotation-xml></semantics></math></span> channels in the endoplasmic reticulum, <span class="math" id="dav_9781319322342_00qKMZywV3" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msub><mrow><mtext>IP</mtext></mrow><mn>3</mn></msub></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="IP Subscript 3" src="../images/MATH/nel_9781319228002_ch12_03EQ_0235.png"/></annotation-xml></semantics></math></span> raises cytosolic <span aria-label="429" epub:type="pagebreak" id="page429" role="doc-pagebreak"/><span class="math" id="dav_9781319322342_5txxhpMtxR" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0236.png"/></annotation-xml></semantics></math></span>. Diacylglycerol and <span class="math" id="dav_9781319322342_tbpI8tUGBX" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0237.png"/></annotation-xml></semantics></math></span> act together to activate protein kinase C, which phosphorylates and changes the activity of specific cellular proteins.</li>
<li id="dav_9781319322342_fk2YwwIEGE"><img alt="" aria-hidden="true" class="decorative size-large" id="dav_9781319322342_Xuk1d0UPYP" role="presentation" src="../images/nelsonlehnpob8e_PG10.png"/> Cellular <span class="math" id="dav_9781319322342_VvI1noaicT" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><mo stretchy="false">[</mo><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo stretchy="false">]</mo></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="left-bracket Ca Superscript 2 plus Baseline right-bracket" src="../images/MATH/nel_9781319228002_ch12_03EQ_0238.png"/></annotation-xml></semantics></math></span> also regulates (often through calmodulin) many other enzymes and proteins involved in secretion, cytoskeletal rearrangements, or contraction. Many of the target enzymes are in the family of <span class="math" id="dav_9781319322342_Fruxnk09Ak" tabindex="0"><math xmlns="http://www.w3.org/1998/Math/MathML" alttext="mathml alt text" display="inline"><semantics><mrow><msup><mrow><mtext>Ca</mtext></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img xmlns="http://www.w3.org/1999/xhtml" alt="Ca Superscript 2 plus" src="../images/MATH/nel_9781319228002_ch12_03EQ_0239.png"/></annotation-xml></semantics></math></span>-activated protein kinases (PKCs).</li>
</ul>
</section>
</section>
</body>
</html>